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Abstract 
 i 
Abstract 
Atomic force microscopy (AFM) based single-molecule force 
spectroscopy (SMFS) is a biophysical tool used to investigate folding and 
unfolding of biological macromolecules, like membrane proteins. 
Unfolding of single membrane proteins can be recorded by force-distance 
(FD) curves, which exhibit reproducible sawtooth-like patterns of force 
peaks. These force peaks reflect the unfolding of stable structural 
segments. In the case of α-helical transmembrane proteins, these 
segments consist of partial or complete α-helices, or even of several 
consecutive α-helices connected by extracellular or intracellular loops. 
Fitting these force peaks using polymer extension models reveals the 
exact position of the interaction within the membrane protein. 
Furthermore, with SMFS based dynamic force spectroscopy (DFS) it is 
possible to study intrinsic behavior of proteins, such as energetic, kinetic 
and mechanical properties, or, in other words, their energy landscape. 
The work presented here contains two SMFS-related projects that were 
carried out independently from each other. However, both projects are 
novel SMFS approaches that improve our understanding of α-helical 
transmembrane proteins. 
In the first project, it was investigated how cholesterol, an 
essential component of eukaryotic membranes, and ligands modulate the 
energy landscape of the human β2 adrenergic G protein-coupled receptor 
(β2AR). G protein-coupled receptors (GPCRs) are a class of versatile 
proteins that transduce signals across membranes. Environmental 
changes induce inter- and intramolecular interactions that change the 
functional state of GPCRs and activate intracellular messenger 
molecules. How these interactions are established and how they modulate 
the functional state of β2AR was addressed in this project. Cholesterol 
considerably increased the kinetic, energetic, and mechanical stability of 
almost every structural segment at sufficient magnitude to alter the 
structure and function relationship of β2AR. One exception was the 
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structural core segment of β2AR, which establishes multiple ligand-
binding sites and which properties were not significantly influenced by 
cholesterol. This suggests that cholesterol may not necessarily influence 
ligand binding to β2AR rather than setting the GPCR into a different 
state so that the receptor will respond differently to ligand binding. For 
that purpose, SMFS and DFS approaches were used to investigate how 
ligand binding modulates the energy landscape of β2AR. Five different 
ligands that represented agonists, inverse agonists or neutral antagonists 
established a complex network of interactions that tuned the kinetic, 
energetic and mechanical properties of functionally important structural 
regions of β2AR. These interactions were specific to the efficacy profile of 
the investigated ligands, which suggests that the functional modulation 
of GPCRs follows structurally well-defined interaction patterns. 
The second project addressed the problem that SMFS is a rather 
time-consuming technique, since the membranes embedding the 
membrane proteins must be imaged and localized before starting the 
actual SFMS measurement. In order to simplify the investigation of 
membrane proteins by SMFS the light-driven proton pump 
bacteriorhodopsin (BR) was reconstituted into lipid nanodiscs. The 
advantage of using nanodiscs is that membrane proteins can be handled 
and characterized like water-soluble proteins with similar ease. SMFS 
characterization of BR in native purple membranes and in nanodiscs 
revealed no significant alterations of structure, function, unfolding 
intermediates, and strengths of inter- and intra-molecular interactions. 
This demonstrates that lipid nanodiscs provide a unique approach for in 
vitro studies of native membrane proteins using SMFS and opens up a 
new avenue to characterize membrane proteins by a wide variety of 
SMFS approaches that have been established on water-soluble proteins.
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Zusammenfassung 
Rasterkraftmikroskopie (AFM) basierte Einzelmolekül-
Kraftspektroskopie (SMFS) ist eine biophysikalische Anwendung, die es 
ermöglicht, Entfaltung und Faltung von biologischen Makromolekülen, 
zum Beispiel von Membranproteinen, zu studieren. Die Entfaltung von 
einzelnen Makromolekülen kann mittels einer Kraft-Abstands-Kurve 
gemessen werden. Eine typische Kraft-Abstands-Kurve, welche die 
Entfaltung eines Transmembranproteins widerspiegelt, weist eine 
sägezahnartige Struktur aus Peaks auf. Jeder dieser Peaks entspricht 
der Entfaltung eines stabilen strukturellen Segments des entfalteten 
Proteins. Bei α-helikalen Transmembranproteinen bestehen diese 
Segmente aus α-Helices (oder Teilen davon), oder sogar aus mehreren 
Transmembransegmenten, welche durch extra- oder intrazelluläre Loops 
miteinander verbunden sind. Die Peaks können mittels physikalischer 
Modelle, die das Verhalten steifer Polymere bei Dehnung beschreiben, 
gefittet werden. Dadurch kann die exakte Position, an welcher innerhalb 
des Membranproteins eine Interaktion auftritt, bestimmt werden. Des 
Weiteren ist es möglich, mit dynamischer Kraftspektroskopie (DFS), ein 
auf SMFS basierendes Verfahren, das intrinsische Verhalten von 
Proteinen zu untersuchen. Beispielsweise können mittels DFS 
biophysikalische Parameter, wie energetische, kinetische und 
mechanische Eigenschaften (Energielandschaft) von Proteinen bestimmt 
werden. Bei der im Folgenden vorgestellten Arbeit handelt es sich um 
zwei voneinander unabhängig durchgeführte SMFS-Projekte. Beide 
Projekte sind neuartige Ansätze, welche unser Verständnis von α-
helikalen Transmembranproteinen verbessern. 
Im ersten Projekt wurde der Einfluss von Cholesterin, einem 
essentiellen Bestandteil eukaryotischer Membranen, auf die 
Energielandschaft des humanen β2 adrenergen G-Protein-gekoppelten 
Rezeptors (β2AR) untersucht. G-Protein-gekoppelte Rezeptoren (GPCRs) 
sind die größte und vielseitigste Gruppe von Membranrezeptoren. 
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Extrazelluläre Veränderungen induzieren inter- und intramolekulare 
Interaktionen, die den funktionellen Zustand von GPCRs modulieren und 
dadurch eine intrazelluläre Signalkaskade auslösen. In dem Projekt 
wurde untersucht, auf welche Art und Weise diese Interaktionen 
etabliert werden und wie sie den funktionellen Zustand des β2ARs 
beeinflussen. Cholesterin hatte einen wesentlichen Einfluss auf die 
Stärke der Interaktionen sowie die Energielandschaft fast aller 
struktureller Segmente des Rezeptors. Eine Ausnahme war das 
strukturelle Kernsegment von β2AR, welches eine Vielzahl von 
Ligandenbindungsstellen aufweist. Die Eigenschaften dieses Segmentes 
blieben auch in Gegenwart von Cholesterin unverändert. Da Cholesterin 
nicht notwendigerweise die Bindung von Liganden beeinflusst, ist zu 
vermuten, dass das Kernsegment seine Eigenschaften ändert, nachdem 
ein Ligand gebunden hat. Um diese Frage zu beantworten wurde mittels 
SMFS und DFS untersucht, wie die Bindung von Liganden an β2AR 
dessen Energielandschaft beeinflusst. Fünf Liganden unterschiedlicher 
therapeutischer Wirksamkeit etablierten ein Netzwerk von 
Interaktionen, welches die kinetischen, energetischen und mechanischen 
Parameter funktionell wichtiger struktureller Regionen des Rezeptors 
modulierte. Diese Interaktionen waren spezifisch entsprechend der 
Wirksamkeit des jeweiligen Liganden. Offenbar folgt die funktionelle 
Modulierung von GPCRs strukturell definierten Interaktionsmustern. 
Bei SMFS von Membranprotein handelt es sich um relativ 
zeitintensive Messungen, da die Membranen, in die das zu untersuchende 
Protein eingebettet ist, zunächst abgebildet und lokalisiert werden 
müssen. Dieses Problem wurde im zweiten Projekt näher betrachtet. Um 
SMFS mit Membranproteinen zu vereinfachen, wurde die lichtgetriebene 
Protonenpumpe Bakteriorhodopsin in Nanodiscs rekonstituiert. 
Nanodiscs sind synthetische Modellmembranen, mittels derer 
Membranproteine ähnlich wie wasserlösliche Proteine behandelt werden 
können. Die Charakterisierung von nativem BR in der Purpurmembran 
sowie in Nanodiscs ergab keine signifikanten Unterschiede bezüglich 
Struktur, Funktion, Entfaltungsintermediaten sowie Stärke von inter- 
Zusammenfassung 
 v 
und intramolekularen Interaktionen. Diese Resultate bestätigen, dass 
Nanodiscs neue Möglichkeiten für SMFS-Studien an Membranproteinen 
in vitro bieten. 
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1 Cell membranes and membrane proteins 
1.1 Cells and their membranes 
It is estimated that there are about 100 million living species on 
earth today (1). Most of them are single cells. Others, for example 
humans, are enormous multicellular complexes in which specialized 
groups of cells perform specific functions and are linked by intricate 
communication systems (1). Nevertheless, all cells on earth share 
common features: hereditary information stored by DNA, DNA 
replication systems, transcription of DNA into RNA, and translation of 
RNA into proteins (1). Thus, every cell on the planet can be regarded as a 
biochemical factory dealing with the same basic molecular building 
blocks: DNA, RNA and proteins. Nevertheless, at least one other univer-
sal component of cells is missing: each cell is confined by a container – the 
plasma membrane. It acts as a selective barrier, enabling the cell to 
concentrate nutrients gathered from the environment, retaining the 
products it synthesizes for its own use and excreting its waste products 
(1). Without the plasma membrane, cells would lose their integrity as 
coordinated chemical systems (1). Complex multicellular organisms, such 
as eukaryotes, have specialized membranes that define different 
organelles, for example endoplasmic reticulum, Golgi apparatus, 
mitochondria, chloroplasts and other membrane-enclosed organelles, 
which maintain the characteristic differences between the contents of 
each organelle and the cytosol (2). 
The membrane consists of a set of amphipathic molecules called 
lipids, which have a hydrophobic (water-insoluble) and a hydrophilic 
(water-soluble) part. Membrane lipids constitute about 50% of the mass of 
most animal cell membranes. Lipid molecules aggregate spontaneously 
when placed in water. They arrange their hydrophobic portions to be as 
much in contact with one another as possible to shield them from water 
molecules whereas their hydrophilic portions are kept exposed (1). 
Cell membranes and membrane proteins 
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Phospholipid molecules comprise most of the plasma membrane 
(1). Phospholipids have a polar headgroup and two hydrophobic 
hydrocarbon tails, usually fatty acids of different lengths (1). They 
spontaneously aggregate in aqueous environment forming a bilayer that 
creates small closed vesicles. This lipid bilayer has been decisively 
established as the universal basis for cell-membrane structure (1). 
The plasma membrane of many mammalian cells contains 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine  (PS) and sphingomyelin (SM). The composition of 
lipids depends on cell type, organelle, and organism (1, 3). Additionally, 
the lipid bilayer of many cell membranes often contains cholesterol1 and 
glycolipids (1, 3). The different types of lipids are not equally distributed 
within the two monolayers (leaflets) of the membrane (4). PS and PE are 
enriched in the cytoplasmic leaflet of the membrane, whereas PC and SM 
are primarily located in the outer monolayer (1, 5). PS is negatively 
charged, which results in a significant difference in charge between the 
two halves of the bilayer. This effect is referred to as the “positive-inside” 
rule (6-9). 
The resulting asymmetry is functionally important. Many proteins 
specifically bind or recognize certain lipid headgroups (10, 11). Animals 
use the phospholipid asymmetry of their plasma membranes to 
discriminate between living and dead cells (1). Furthermore, the 
distribution of lipids influences protein folding, assembly (12) and activity 
(13, 14). 
The “fluid mosaic model”, which has been proposed by Singer and 
Nicolson in 1972, describes membranes as an oriented, dynamic, two 
dimensional, and viscous solution of proteins and lipids (15). However, it 
turned out that membranes are more mosaic than fluid (16). Membrane 
proteins undergo restrained or directed motion within membranes (17). 
                                            
1 Cholesterol reduces the permeability of membranes to small water-soluble molecules 
(1). It can be predominantly found in eukaryotic plasma membranes, since they contain 
large amounts of cholesterol. 
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They are often organized in large functionally relevant supramolecular 
complexes, such as the respiratory chain complexes I, III and IV (18) and 
photosystems I and II (19). In addition, membranes contain 
microdomains, or lipid rafts, which are enriched in sphingolipids, 
cholesterol and membrane proteins (1). 
1.2 Membrane proteins 
For cells to function properly, membranes must not be completely 
impermeable. A cell must be able to import raw materials and export 
waste across its membranes. To transfer specific molecules from one side 
to the other, cells have specialized proteins embedded in their membrane. 
These transport proteins mainly determine which molecules can enter or 
exit the cell. Furthermore, all cells have membrane proteins that act as 
sensors of external stimuli, allowing the cell to change its behavior in 
response to environmental signals. Instead of molecules, these protein 
sensors, or receptors, transfer information across the membrane (1). 
Why are membrane proteins such an interesting and important 
field of research? In fact, 20-30% of all open reading frames in the genome 
of eubacterial, archaean, and eukaryotic organisms encode integral 
membrane proteins (20), indicating the importance of this class of 
proteins. Since membrane proteins are located at the boundaries of cells 
and other membrane-enclosed organelles, they are involved in all 
processes that require signal transduction across the membrane. They 
transport solubles, like toxic compounds and nutrients. Moreover, they 
play important roles in energy conversion and cell adhesion (1). Since 
they are involved in so many processes, they are important targets for 
drugs. Actually, about 70% of all drug targets are membrane proteins (21, 
22). Mutations in membrane proteins can be the cause of a multitude of 
diseases, for example cystic fibrosis and retinitis pigmentosa (23, 24). To 
develop new drugs and understand the molecular processes behind these 
diseases, it is of major importance to gain insight into structural and 
functional mechanisms of membrane proteins. However, compared to 
soluble proteins, the amount of membrane protein structures in the 
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Protein Data Bank (PDB)2 (25) is underrepresented. Because of the slow 
progress of membrane protein structure determination (26), structures 
and functional mechanisms of membrane proteins are poorly understood. 
Two protein secondary structure motifs capable of passing the 
membrane have been observed: α-helical bundles and antiparallel β-
strands (Figure 1.1). The great majority of membrane-spanning 
segments traverse the bilayer forming a α-helical bundle. α-helical 
membrane proteins contribute to active transport of solubles, signaling, 
and communication with other cells. In contrast, β-barrel membrane 
proteins arrange their transmembrane strands as a β-sheet in the form of 
a barrel. These proteins can be found in the outer membrane of Gram-
positive bacteria. In eukaryotes, β-barrel proteins are abundant in the 
outer membrane of mitochondria and chloroplasts 3 . However, the 
majority of multipass transmembrane proteins in the bacterial plasma 
membrane and in eukaryotic cells are composed of transmembrane α-
helices (1). 
  
                                            
2 On June 4, 2012, the search for membrane and cell surface proteins and peptides in the 
PDB resulted in 615 hits. The PDB contained 75885 protein structures at that day. 
3 Structure, assembly and folding of β-barrel membrane proteins are reviewed in (27-31). 
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Figure 1.1: The two major structural motifs found in membrane proteins. (A) 
The heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor 
rhodopsin from bovine rod outer segment (ROS). The transmembrane region contains 
seven α-helical bundles, which are connected by extramembrane loops. PDB ID: 1F88 
(32). (B) The OmpG protein from Escherichia coli is a β-barrel protein composed of 14 
antiparallel β-strands. PDB ID: 2FIC (33). Both proteins are shown in side-view. 
1.2.1 Folding of membrane proteins 
1.2.1.1 Sec-dependent insertion 
One important step during the lifetime of a membrane protein is 
its insertion into the lipid bilayer, a process that follows protein 
synthesis. Exhaustive functional studies on bacterial and eukaryotic 
homologues of the archaeabacterial protein-translocating SecYEG 
channel have significantly advanced our understanding of the molecular 
mechanisms that guide folding and insertion of membrane proteins (34-
38). 
The process of membrane protein folding and insertion is 
facilitated and controlled by the so-called translocon protein machinery 
(36, 37). It consists of a hydrophilic cavity with a diameter of a few tens of 
Ångströms, and a ribosome-binding site, which is displayed towards the 
cytoplasm. The N-terminal portion of a nascent polypeptide chain of a 
membrane protein contains a signal sequence in the N-terminal part that 
targets the ribosome-peptide complex to the translocon. After binding of 
the ribosome to the translocon, the nascent polypeptide chain is directly 
expelled from the ribosomal exit tunnel into the pore of the translocon. 
The translocon can accommodate peptides with a length of ≈20 aa, which 
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is sufficient to form an α-helical transmembrane segment. The peptide 
exits the translocon through a lateral gate. The gate might open and close 
periodically (39) in order to allow the segment to sense and partition into 
the lipid bilayer (40). As indicated by the size of the pore, transmembrane 
segments laterally exit the translocon one by one or pairwise (41, 42). 
While hydrophobic sequences are inserted into the membrane, 
hydrophilic sequences pass through the aqueous pore or emerge between 
the translocon and the ribosome. 
1.2.1.2 Insertion models 
Popot and Engelman introduced models, which describe the folding 
and insertion of membrane proteins into a membrane (43, 44). In the two-
stage model, the membrane protein inserts into the lipid bilayer in a 
process driven by a translocon. Secondary structure elements like the α-
helical bundle are formed in this step. In contrast to soluble proteins, 
whose three-dimensional fold is dictated by their amino acid sequences 
(45), the folding of a membrane protein requires the interplay between 
ribosome and the translocon machinery. In the second step, the actual 
membrane protein folding process takes place, including the formation of 
the correct tertiary or quaternary structure. Furthermore, the 
transmembrane elements need to rearrange and reorient to adopt the 
correct fold. The formation of additional structural elements (e.g. re-
entrant loops), binding of cofactors or oligomerization can be combined in 
a third step. 
The dimerization of α-helical bundles is promoted by specific amino 
acid sequence motifs within the peptide (e.g. GxxxG) (46-48). This process 
optimizes the packing of helices through van-der-Waals interactions (46). 
In addition, the formation of interhelical hydrogen bonds can be observed 
even in early stages of the translocon-mediated protein insertion (49). 
Although the two-stage folding model for membrane proteins 
appears simple, it provides an explanation of many experimental data. 
For instance, it has been shown that peptide fragments of membrane 
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proteins can be independently refolded or synthesized and assemble into 
functional proteins (50). 
Despite its simplicity, the two-stage model does not provide 
answers to certain questions, for example how and when transmembrane 
α-helices are formed. Also, it does not explain the principles behind this 
process. The four-step model provides a more detailed insight based on 
experimental data such as folding and insertion of synthetic peptides and 
small proteins into lipid bilayers (51). It includes the following steps: 
(i) partitioning of the unfolded polypeptide chain in the interface region of 
the membrane, (ii) folding of the α-helical segment, (iii) insertion of the α-
helical segment, and finally (iv) association of α-helical transmembrane 
segments (Figure 1.2). The membrane interface provides a local free 
energy minimum for binding and the subsequent folding of hydrophobic 
peptides (52-54). The minimization of the free energy is the driving factor 
behind this process. 
 
Figure 1.2: The four-step model of membrane protein folding. (1) Partitioning of 
the unfolded polypeptide chain. (2) Folding of α-helical segments. (3) Insertion of α-
helical segments. (4) Association of α-helical segments (5) Optional: assisted folding by a 
chaperone (green). 
1.2.2 Membrane protein research – a challenge 
As mentioned in section 1.1, there are still considerable difficulties 
in membrane protein research. The repertoire of reliable methods to 
produce, purify, solubilize and reconstitute or crystallize a membrane 
protein is limited, compared to the techniques available for water-soluble 
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proteins. To make things worse, the handling of a membrane protein is 
much trickier than working with a water-soluble protein. 
The concentration of membrane proteins in the native membrane is 
usually very low 4 . Therefore, approaches to overexpress membrane 
proteins are required (56-58). Overexpressed proteins can accumulate in 
the membrane, which may induce stress response mechanisms or can 
have other cytotoxic effects (58). Moreover, it is difficult to express 
eukaryotic membrane proteins in bacteria, since they do not fulfill certain 
requirements, such as specific glycosylation (58, 59) or lipid composition 
of the membrane (13, 60). In addition, translation rates differ between 
prokaryotes and eukaryotes, which eventually leads to aggregation and 
misfolding of the membrane protein of interest (56). The complexity of the 
cellular membrane further complicates purification of functional 
membrane proteins. 
Membrane proteins can be solubilized by detergents, which 
stabilize the protein in aqueous solutions (61, 62). Since the (long-term) 
stability of membrane proteins depends on the nature of the solubilizing 
agents (57, 62) the choice of detergent is possibly the most important 
decision to make when purifying a membrane protein. Alternatively, 
membrane proteins can be solubilized using polymers with a hydrophilic 
backbone and hydrophobic side chains, so-called amphipols (63). 
1.2.3 Approaches to study membrane proteins 
As discussed in the previous section, structure determination of 
membrane protein research remains an intricate challenge. Due to the 
enormous number of crystallization conditions that have to be screened 
and the low stability of solubilized membrane proteins, the growth of 
well-diffracting three-dimensional (3D) crystals for X-ray crystallography 
is very time-consuming. 
                                            
4 Some proteins are available in large quantities from their native membrane, for 
example bacteriorhodopsin (55). Therefore they can be purified from their natural 
sources. 
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Novel approaches, like the lipid cubic phase (64), fusion with large 
hydrophilic domains (65), and the use of antibody fragments (66) to 
improve crystallization of membrane proteins did not significantly 
accelerate the pace of structure determination. Nevertheless, this 
problem can be overcome by the use of electron microscopy (EM) (67). EM 
requires the arrangement of proteins in a two-dimensional (2D) planar 
ordered structure (68). An increase in resolution to near-atomic level (69) 
can be achieved by freezing the sample, a technique called cryo-EM (70). 
Besides, single-particle EM techniques to approach large proteins yield in 
medium resolution (8-30 Å), allowing observation of functionally related 
conformational changes (71). Furthermore, nuclear magnetic resonance 
(NMR) approaches, such as solution NMR (72), solid-state NMR (73) and 
magic-angle spinning NMR (74) provide increasing possibilities to study 
structure and dynamics of membrane protein complexes. 
Besides these relatively new techniques, “classical” methods are 
still indispensable in membrane protein research. Important approaches 
are circular dichroism (CD) spectroscopy (75, 76), time-resolved Fourier 
transform infrared (FTIR) spectroscopy (77, 78), several different types of 
fluorescence spectroscopy (75, 79), calorimetric studies (80, 81) and 
electrophysiological techniques (82-84). 
In addition to the experimental methods to study membrane 
proteins, computational tools have emerged in the past years. They gain 
importance since they strengthen or validate experimental data for these 
different methods. Additionally, the transmembrane topology based on 
sequence analysis can be predicted. The potential of molecular dynamics 
(MD) simulations is illustrated through modeling of structure and 
function of G protein-coupled receptors (GPCRs) (85, 86) and unfolding of 
bacteriorhodopsin (BR) (87, 88). 
There is one more method for studying membrane proteins that 
has not been mentioned so far: the atomic force microscope (AFM), a 
powerful tool to address single membrane proteins. The AFM will be 
described in the following chapter.
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2 The atomic force microscope 
2.1 History 
Stockholm, Wednesday, December 10, 1986. The Nobel Prize in 
Physics has just been awarded to two scientists, Gerd Binning and 
Heinrich Rohrer, for their outstanding invention: the scanning tunneling 
microscope (STM). The STM, which uses a sharp tip to probe a surface, 
revolutionized microscopy. The tip “may be a fine needle, which is moved 
across the surface of the structure to be investigated. […] This is just the 
beginning of an extremely promising and fascinating development. The 
old dream from antiquity of a visible image of the atomic structure of 
matter is beginning to look like a realistic possibility, thanks to progress 
in modern microscopy”5. 
The STM showed the atomic structure at the crystalline surface of 
silicon and demonstrated the possibility to manipulate single atoms (89). 
However, the STM is limited to conducting surfaces, because it relies on 
tunnel currents between tip and surface. In 1986, Binnig and Rohrer 
received the Nobel Prize in Physics for their discovery. In the same year, 
Binnig together with Quate and Gerber introduced the atomic force 
microscope (AFM) (90) to image both conducting and non-conducting 
surfaces. Although true atomic resolution is only possible under ultrahigh 
vacuum and with atomically flat surfaces (91), the AFM impresses by its 
high spatial resolution. Both STM and AFM are members of the scanning 
probe microscopy (SPM) family. 
Today AFMs are commercially available. They have evolved 
through several generations since the early 1990s. Many different types 
of AFMs have been developed that can be used not only for measuring the 
topologies of surfaces, but also for measuring the properties of various 
materials at or close to surfaces. With a resolution down to either atomic 
                                            
5  Excerpt from the Award Ceremony Speech. Nobelprize.org 4 Jun 2012 
http://nobelprize.org/nobel_prizes/physics/laureates/1986/presentation-speech.html 
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or molecular level, this can be done in a broad temperature range in 
vacuum, gas, or in liquids.  
2.2 Atomic force microscopy in biophysics 
Over the past decades, the AFM has emerged into a versatile tool 
to study structural and mechanical properties of biological samples such 
as proteins and biological membranes (92). One advantage is the fact that 
these studies can be carried out under close to native conditions. For 
instance, Andreas Engel and Daniel J. Müller developed tools for high-
resolution imaging of membrane proteins (93). With these methods it 
became possible to acquire images with a lateral resolution of ≈5 Å and a 
vertical resolution of ≈1 Å. Using AFM imaging of reconstituted 
membrane proteins and native membranes biophysicists gained insight 
into high-resolution information about the topography (94-103), 
conformational changes (101, 103-108), oligomeric states (109-122), or 
dynamic process of membrane proteins (123, 124). Furthermore, AFM 
based single-molecule force spectroscopy (SMFS, see section 2.8.1) has 
emerged into a tool to investigate unfolding and folding of membrane 
proteins (92, 125). Prior to an SMFS experiment, membrane proteins 
reconstituted into lipid bilayers are adsorbed on a flat surface and 
attached to the AFM cantilever with one of their termini (see section 2.6). 
In the actual SMFS measurement, the cantilever is retracted and the 
protein is stretched. During this process, the membrane protein is 
unfolded in a sequential manner. With the help of SMFS, interactions 
that stabilize membrane proteins can be determined (92). Furthermore, 
these interactions are located within the membrane protein structures 
using polymer extension models (see section 2.8.2). 
It has already been shown that SMFS can address the effect of 
environmental changes on the membrane protein, for example 
temperature (126), ligands (127-131), ions (132, 133), inhibitors (134), 
point mutations (135), oligomeric states (136), pH (137) or the functional 
state of the protein (127, 128). A change in environmental factors affects 
molecular interactions that stabilize membrane proteins. This results in 
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changes in the unfolding spectra (125). An extension of SMFS uses 
unfolding at different velocities. This method is called dynamic force 
spectroscopy (DFS) and reveals parameters that are specific for the 
energy landscape of single membrane proteins (see section 2.8.3). 
In addition to mechanical unfolding of membrane proteins, it is 
also possible to study their refolding into lipid bilayers (138, 139). In 
these unfolding experiments, the membrane protein is partially unfolded, 
leaving one mechanical anchor in the membrane. In the next step, the 
cantilever approaches the surface again, which relaxes the unfolded 
polypeptide chain and allows reinsertion of the peptide or parts of it into 
the lipid bilayer. The folding kinetics of a single membrane protein can be 
evaluated by changing the time before the cantilever is retracted again to 
completely unfold the protein. 
2.3 Instrumental setup 
At first sight, the AFM seems to be a complicated instrument. 
Nevertheless, it works on a very simple principle and it is probably one of 
the easiest microscopy techniques to learn and understand. The 
instrumental setup of an AFM is simple (Figure 2.1). It consists of only 
three key components: i) a cantilever with a sharp tip or stylus at its end, 
ii) a piezoelectric transducer or actuator, which moves the sample 
mounted on its top in three dimensions with sub-nanometer precision6, 
and iii) an optic detection system that consists of a laser diode and a 
position sensitive photodiode (PSPD) with four quadrants for accurate 
detection of vertical and lateral displacement of the laser beam. Finally, a 
computer is required to control the AFM. 
                                            
6 AFMs from Bruker (formerly Veeco, DI) change the position of the sample. Other AFM 
instruments (e.g. JPK) move the cantilever for x-y-scanning and vertical adjustment in 
z-direction. 
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Figure 2.1: Schematic illustration of a typical AFM setup. A laser beam is focused 
on the backside of the cantilever. A mirror directs the reflected beam onto the 
photodiode (PSPD). Deflection of the cantilever changes the position of the laser spot on 
the PSPD, resulting in a signal, which is transferred to the controller. The controller 
processes the signal and sends a feedback signal to the piezoelectric transducer. Thus, 
the height of the surface is adjusted according to the feedback signal. 
Before setting up an AFM experiment, the cantilever needs to be 
mounted on a fluid cell or glass block (not shown in Figure 2.1). Next, 
the laser beam is focused on the backside of the cantilever, from where it 
is reflected onto a mirror. The mirror directs the laser beam to the PSPD. 
Deflection of the cantilever changes the position of the laser spot on the 
PSPD. This change is transferred to the controller, which records the 
incoming information, processes it, and converts it into a feedback signal. 
Then the signal is sent to the piezoelectric actuator, which adjusts the 
height, or z-position of the sample, in order to change the deflection of the 
cantilever. Thus, the contact force between the AFM tip and the sample 
surface is changed as well. 
2.4 Cantilevers 
The cantilever with a sharp tip at its end is the most important 
part of an AFM, since it interacts with the sample. Modern AFM 
cantilevers and tips are commonly made from silicon, silicon-nitride 
(Si3N4) or diamond. Usually cantilevers are rectangular or triangular 
shaped with a length of 50-200 µm and a thickness of 0.5-2 µm. They are 
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often coated with a thin layer of gold or aluminum for efficient reflection 
of the laser beam. Depending on the application, one can choose among 
cantilevers with different physical properties. Cantilevers used for high-
resolution contact mode imaging have a spring constant of ≈0.05-0.2 N/m. 
Highly sensitive low-noise SMFS experiments require cantilevers with a 
spring constant of ≈0.03 N/m. However, spring constants of cantilevers 
used for non-contact mode applications are significantly higher by a 
factor of ≈10. 
It can be assumed that the cantilever acts like a Hookean spring7 
with the spring constant !. Therefore, the bending of the cantilever, !", 
can be converted into force: ! = !  ×  !" Equation 2.1 
The force value usually lies in the range of piconewton (pN) to 
nanonewton (nN). 
The spring constant of a cantilever is principally affected by its 
geometrical properties, such as length, width and thickness. Additionally, 
the material of a cantilever (Young’s modulus) further affects the spring 
constant. Equation 2.2 gives the theoretical spring constant of a 
rectangular cantilever. 
! = !!!!4!!  Equation 2.2 ! is the Young’s modulus, ! is the thickness, ! is the width and ! is the 
length of the cantilever (140). Typically, for biological AFM applications, 
rectangular or triangular cantilevers are used. 
2.5 Calibration 
2.5.1 Calibration of the photo-detection system 
Calibrating the photo-detection system of the AFM followed by 
determination of the cantilever spring constant (see following section) is 
                                            
7 Assuming that cantilevers act like Hookean springs, this assumption is only valid for 
small deflections (several tens of nanometers). Cantilevers do not behave as linear 
springs at higher deflections anymore. 
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obligatory for precise force measurements. During all calibration 
procedures, the cantilever is immersed in liquid, and a solid supporting 
surface is required. The x,y-position of the cantilever relative to the 
sample is kept constant while the piezo-actuator is repeatedly extended 
and retracted in the vertical (z-) direction by a certain distance. The beam 
deflection in the contact area is recorded during these approach-and-
retract cycles. This allows the correlation between the beam displacement 
on the PSPD in Volt (V) and the piezo-actuator in nm.  
Figure 2.2 on the next page illustrates how the deflection signal 
changes when the cantilever stylus gets into contact with the surface 
during an approach-and-retract cycle: 
1. The cantilever is away from the surface. Fluctuations in the 
deflection signal are caused by thermal noise.  
2. Next, the piezo-actuator is extended until the cantilever tip 
gets into contact with the surface. 
3. The cantilever bends upwards until the end of the piezo 
extension, leading to a linear increase in the signal on the 
PSPD.  
4. The piezo is retracted. The decrease in the bending of the 
cantilever is displayed by the linear decrease in the deflection 
signal. The deflection sensitivity (rate of signal strength 
correlated to extension in V/nm) can now be determined by 
fitting a line to this contact regime. 
5. Usually, the cantilever sticks to the surface and bends 
downwards during piezo retraction, which results in a 
negative deflection signal, also called adhesion peak. 
6. Further retraction of the piezo releases the cantilever from its 
interaction with the surface. Thus, it loses contact and relaxes 
into its original non-bent position. 
Thus, after calibration of the photo-detection system, a measured 
voltage signal of the PSPD can be easily converted into a metric 
cantilever deflection. 
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Figure 2.2: Deflection of the cantilever during an approach-and-retract cycle. 
For calibrating the deflection sensitivity of the PSPD detection system, the piezo-
scanner is extended until the cantilever reaches the surface and deflects (1-3). Then, the 
scanner is retracted at constant speed and the cantilever relaxes (4-6). Thus, the piezo-
extension can be directly correlated to the linear increase in the deflection of the 
cantilever (3 and 4). 
2.5.2 Calibration of the cantilever spring constant  
There are several possibilities to calculate the spring constant of an 
AFM cantilever (141). The most common method used for the calibration 
of AFM cantilevers is the so-called “thermal tuning” that was introduced 
by Hutter and Bechhoefer (142). The cantilever needs to be kept in 
solution, at a fixed position at least 50 µm away from the surface. 
Brownian motions induce minor free oscillations of the cantilever. After 
Fourier transformation of the free oscillation frequencies of the cantilever 
recorded over several seconds, a probability-oscillation frequency plot is 
generated. The resulting curve can be fitted with a power law, which 
allows determination of the actual spring constant of the respective 
cantilever. Measured spring constants can easily deviate by 50% 
compared to nominal spring constants provided by the manufacturer. 
This underlines the necessity of the calibration procedure. 
The atomic force microscope 
 18 
2.6 Sample and support preparation 
In order to investigate a sample by AFM, it has to be adsorbed on a 
surface. This process is usually facilitated by physisorption (143) and 
strongly depends on the surface charges of both the supporting surface 
and the sample. The concentration of the sample as well as the 
adsorption time determine the adsorption efficiency, which can be 
optimized by minimizing repulsive electrostatic forces between sample 
and surface (143). Thus, the successful adsorption of a sample requires 
the careful adjustment of the electrolyte concentration and pH conditions. 
Furthermore, an appropriate surface is required on which the sample can 
be adsorbed. Adding cations balances the negative surface charge and 
leads to increased van-der-Waals interactions between sample and 
surface. 
A commonly used surface for AFM studies on membrane proteins 
is negatively charged muscovite (mica). Mica was used as a supporting 
surface throughout the work presented in chapter 3 and chapter 4. 
Further supporting surfaces used for AFM experiments are highly 
ordered pyrolytic graphite (HOPG) (106), ultraflat gold (144, 145) or glass 
(146, 147). However, due to their hydrophobicity those materials might 
lead to destruction of the investigated membrane protein. For that 
reason, mica surfaces are the first choice for AFM studies on membrane 
proteins. 
Usually a small piece of mica is glued onto a metal disc or onto a 
glass slide to ensure lateral fixation of the sample on the piezo-scanner 
(93). To adsorb a sample, it needs to be diluted in an appropriate buffer 
and subsequently placed on a clean surface. After an adequate adsorption 
time the surface needs to be washed several times. The AFM cantilever 
needs to be mounted on top of the sample. Normally, thermal 
equilibration requires several minutes before the experiment can be 
started. 
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2.7 Contact mode imaging 
In order to determine the topography of a surface, the AFM tip 
needs to be scanned over the area of interest in a raster-like manner. The 
bending of the cantilever provides information on the vertical dimension 
of the surface. In contact-mode imaging, the bending of the cantilever 
and, thus, the interaction force between tip and surface are kept constant 
by adjusting a user-defined value (set point). For that purpose, the height 
of the sample is constantly adjusted by the piezo movement. This imaging 
mode is also referred to as constant force mode. Usually, the scanning 
force is kept low (≈100 pN) in order to minimize alterations or distortion 
of topographical features of the sample. Contact mode imaging facilitated 
high-resolution images of several membrane proteins, like 
bacteriorhodopsin (BR) (148), connexin channels (103), the c-rings of ATP 
synthase (119) and the β-barrel protein OmpG (107). 
2.8 AFM-based force measurements 
Introduced to image the topography of inorganic surfaces in 
vacuum at nanometer precision (90), the AFM has emerged into a 
multifunctional toolbox in nanobiotechnology (149). One of a multitude of 
the currently used AFM techniques is an approach called single-molecule 
force spectroscopy (SMFS), which will be described in the next section. 
2.8.1 Single-molecule force spectroscopy (SMFS) 
Single-molecule force spectroscopy (SMFS) is an AFM technique, 
which uses force to unfold single proteins. SMFS has been introduced by 
Gaub (150) and Lee (151) to probe the strength of receptor-ligand bonds. 
All SMFS experiments that have been conducted so far demonstrated 
that the forces probed by SMFS reflect interactions within or between 
molecules. Unraveling the mechanisms of protein folding and unfolding, 
receptor-ligand interactions, and ligand-binding interactions that switch 
the functional state of a protein are only a small number of biologically 
and medically pertinent questions that can be answered by SMFS (149). 
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The first protein investigated by SMFS (and probably the best-
studied one) is the immunoglobulin titin (152). In the muscle sarcomeres 
of humans, the titin filament acts as an adjustable molecular spring. 
About 90% of the titin filaments are immunoglobulin (IG) domains that 
provide mechanical elasticity to the filament (153). Reversible unfolding 
of an oligomeric titin construct was achieved by simply applying a 
mechanical pulling force to both ends of the peptide. Recording the 
applied force over the distance the peptide has been stretched revealed a 
characteristic sawtooth-like pattern of force peaks. Every single force 
peak of this pattern reflected unfolding of a single IG domain of the 
peptide, whereas the sequence of force peaks described the unfolding 
pathways of all IG domains within the oligomeric titin construct. 
The light-driven proton pump bacteriorhodopsin (BR) from 
Halobacterium salinarum8 was the first membrane protein studied by 
SMFS (156). BR is an ideal model for SMFS on membrane proteins, since 
its atomic structure is known (64, 157). Furthermore, it is easy to purify 
and naturally abundant. Thus, an enormous amount of function-related 
biochemical data on BR is available (158). In SMFS experiments, single 
BR molecules withstand forces of up to 200 pN before their structural 
segments unfold cooperatively (159) (see chapter 4). Mechanical unfolding 
of BR occurs along a few highly reproducible pathways, which are 
temperature-dependent (126, 159). 
2.8.2 Polymer extension models 
In order to describe the stretching of flexible polymer chains the 
freely jointed chain model was developed (160). From this model, the 
worm-like chain (WLC) model emerged (161). The WLC model describes 
the extension of semi-flexible polymer chains (161, 162). The force ! 
required to stretch the polymer chain is given by 
                                            
8  Halobacterium salinarum is a halophilic marine Gram-negative obligate aerobic 
archaeon (154, 155). 
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! ! =   !!!!!    0.25 1− !!! !! − 0.25+ !!!  Equation 2.3 
where !! is the Boltzmann constant9 and ! is the absolute temperature. !!  is the persistence length of the polymer and describes its rigidity. 
Values for !! are specific for each polymer and must be experimentally 
determined (163). A persistence length of 4 Å has been successfully 
applied to describe the extension at forces higher than 50 pN (152, 156). 
F-D curves recorded upon unfolding of single polypeptides can be fitted 
using the WLC model (164). The contour length !! (in aa) obtained from 
fitting a force peak using the WLC model describes the length of the 
polypeptide that had been unfolded and stretched. The WLC model was 
used throughout all projects in the work presented here. 
2.8.3 Dynamic force spectroscopy (DFS) 
The mechanical stability of an interaction cannot be adequately 
characterized by its strength. In addition to the strength, the lifetime of 
an interaction has to be taken into consideration. 
Dynamic force spectroscopy (DFS) is an extension of SMFS. DFS 
probes molecular bonds at different loading rates (applied force over 
time), allowing the approximation of the transition state and kinetic rate 
of the energy barrier of the bond (165). 
Usually, the bound state of an interaction is characterized by the 
state of the lowest energy. Thus, in order to disrupt an interaction, it has 
to be transferred from this local energy minimum into the unbound state 
of unknown energy. To do so, the unfolding energy barrier must be 
overcome by a sufficient amount of energy in the direction of the reaction 
coordinate. The investigation of the folding and unfolding of soluble 
proteins revealed that these processes could be described by a two-state 
model (166, 167). In this model, folded structures exist either in a low-
energy, low-entropic conformation, which corresponds to the native folded 
state. The high-energy, high-entropic state corresponds to the unfolded 
                                            
9 !!=1.3810-23 J/K 
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state of the protein. Both states are separated by an energy barrier 
(Figure 2.3A). The unfolding process can be modeled as a thermally 
driven overdamped first-order kinetic process in an aqueous environment 
described by the unfolding rate !!, which is given by  !! = !!!!!"# −∆!!‡!!!  Equation 2.4 
where !! is the diffuse relaxation time, which lies in the range of 10-7-10-9 
s (168, 169) and ∆!!‡ is the activation free energy. Equation 2.3 gives the 
expression for the spontaneous unfolding rate in the absence of applied 
force. 
Since most proteins are kept in their native conformation by non-
covalent interactions with limited lifetime, these bonds can break even in 
the absence of any applied force. According to Equation 2.4, the 
unfolding rate !!  increases when the activation free energy ∆!!‡ 
decreases. Application of an externally applied unfolding force  ! leads to 
a decrease in ∆!!‡:  ∆!‡ ! = ∆!!‡ − !!! Equation 2.5 
where !! is the length along the reaction coordinate. !! is defined by  !! = !!cos  (!) Equation 2.6 
Thus, application of an external unfolding force adds a mechanical 
unfolding potential (–!cos  (!)!!), which results in a tilt in the energy 
landscape (Figure 2.3B). !!  is the distance between folded and the 
transition state along the reaction coordinate, whereas !  is the angle of 
the externally applied force relative to the reaction coordinate. For single-
molecule force experiments it can be assumed that !  is small, so that !! ≈ !!. Therefore, the unfolding rate under an externally applied force ! 
is given by 
! ! = !!!!!"# −∆!!‡ − !!!!!!  Equation 2.7 
The transition rate across the energy barrier and the force required 
to break an interaction both depend on the rate and duration of the 
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applied force (165, 170, 171). The most probable unfolding force !∗ 
depends on the most probable loading rate !!∗, which is the slope of a force 
peak multiplied by the speed of unfolding (165, 171): 
!∗ = !!!!! !" !!!!∗!!!!!  Equation 2.8 
In general, AFM-based SMFS does not allow performing 
experiments under equilibrium conditions. Nevertheless, biophysicists 
are interested in parameters that describe the untilted energy landscape 
at equilibrium, such as !!,  !! and ∆!!‡. To extract these parameters, one 
needs to measure the most probable unfolding force !∗ of a rupture event 
at different loading rates using DFS. The data obtained from these DFS 
unfolding experiments can be fitted using Equation 2.8. The ground-to-
transition state distance !! can be obtained from the slope of the DFS fit 
(!∗  vs !"(!!∗)). The height of the activation energy barrier ∆!!‡  can be 
calculated using an the Arrhenius equation: ∆!!‡ = −!!!"#(!!!!) Equation 2.9 
The energy landscape illustrated in Figure 2.3 is an 
oversimplification, since the structures of soluble and membrane proteins 
are stabilized by weak non-covalent interactions, for example ionic bonds, 
hydrogen bonds and van-der-Waals interactions. These interactions break 
when the protein is transferred from the native state into the completely 
stretched and unfolded state. Thus, a large number of energy barriers 
have to be overcome during the folding or unfolding of a protein, which 
results in a rough energy landscape as indicated in Figure 2.3 (172-176). 
Therefore, DFS experiments locate and quantify only the most prominent 
energy barriers, while minor energy barriers might not be detected. 
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Figure 2.3: Free energy unfolding barrier describing energetic (∆!!‡ ) and 
kinetic (!! and !!) parameters of stable structural segments. (A) According to the 
Bell-Evans model (165, 177), folded structures can be characterized using a simple two-
state model. The native, folded structure resides in an energy valley and is separated by 
an energy barrier from the unfolded state. As approximated previously the surface 
roughness of the energy landscape of transmembrane α-helices, ε, is ≈4-6 !!! (178). This 
roughness creates local energy minima that can stabilize functionally related 
conformational states of a structural segment. Thus, for a given surface roughness, a 
wide energy valley can host more conformational states (i.e., hosts a higher 
conformational variability) of a structural segment compared to a narrow energy valley. 
The transition state (‡) has to be overcome to induce unfolding of the stable structural 
segment. !! represents the distance between the folded state and the transition state, !! 
is the transition rate for crossing the energy barrier under zero force, and ∆!!‡ gives the 
activation energy for unfolding the segment. (B) Applying an external force ! changes 
the thermal likelihood of reaching the top of the energy barrier. The energy profile along 
the reaction coordinate (pulling direction) is tilted by the mechanical energy –!cos  (!)!!, as indicated by the dashed line. The applied force does not change the 
ground-to-transition state distance !!. ! describes the angle of the externally applied 
force relative to the reaction coordinate. As a result of this tilt, the energy barrier that 
separates the folded from the unfolded state decreases and the probability of the folded 
structural segment to unfold increases. 
 
Molecular interactions of the human β2AR 
 25 
3 Molecular interactions of the human G 
protein-coupled β2 adrenergic receptor 
Parts of this work have been submitted to PNAS and Structure for 
consideration. 
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3.1 Introduction 
Over the past four years remarkable advances in the structural 
biology of G protein-coupled receptors (GPCRs) have been made. One of 
the highlights includes solving the crystal structure of the human β2 
adrenergic G protein-coupled receptor (β2AR) (65, 66), an outstanding 
success of great interest, in particular from the perspective of membrane-
protein biophysics. 
3.1.1 Multifaceted functionality of GPCRs 
What is it that makes this family of membrane proteins so 
interesting? First of all, GPCRs are the largest family of membrane 
proteins mediating most cellular responses to hormones and 
neurotransmitters. Furthermore, GPCRs are responsible for olfaction, 
taste and vision. All GPCRs contain seven membrane-spanning α-helical 
segments, which are separated by alternating intracellular and 
extracellular loops. In vertebrates, GPCRs can be divided into five 
families. Depending on their sequence and structural similarity, they are 
divided into rhodopsin-like (family A), secretin (family B), glutamate 
(family C), adhesion and frizzled/taste2 (179). The rhodopsin family is by 
far the largest and most diverse of these families. Members of family A 
are characterized by conserved sequence motifs implying shared 
activation mechanisms and structural features. Nevertheless, individual 
GPCRs have unique combinations of signal-transduction activities that 
involve multiple G protein subtypes. In addition, they initiate complex 
regulatory processes (180). Due to their broad influence over human 
physiology and behavior, GPCRs are promising targets for new and more 
effective drugs. 
The β2AR is one of the best-characterized GPCRs. β2AR belongs to 
the class A GPCRs and is expressed in pulmonary and cardiac myocyte 
tissue (181, 182). Together with its close relative β1AR, β2AR senses 
adrenalin in bronchial vasculature and noradrenalin in cardiac muscle. 
The implication in a broad spectrum of diseases like asthma or heart 
failure makes β2AR an important therapeutic target (183-187). Numerous 
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ligands that bind to β2AR are used as drugs in cardiac disease and 
asthma treatment (183). Several crystal structures of β2AR have been 
determined over the last years (65, 66, 188-191), providing unique 
insights into structure-function relationships of GPCRs. 
In general, the classical role of a GPCR is to couple the binding of 
agonists to activation of specific heterotrimeric G proteins, which leads to 
the modulation of downstream effector proteins. In the case of β2AR, 
binding of adrenalin and noradrenalin to cells in the target tissues of 
sympathetic neurotransmission leads to activation of Gαs, the 
stimulatory subunit of the heterotrimeric G protein. Gαs stimulates 
adenylate cyclase, cyclic (cAMP) accumulates, the cAMP-dependent 
protein kinase A (PKA) is activated, and proteins involved in muscle-cell 
contraction are phosphorylated (192). Nevertheless, in recent years it has 
been shown that many GPCRs exhibit a much more complex signaling 
behavior. For instance, β2AR has a significant constitutive activity, which 
can be blocked by inverse agonists (193, 194). Besides Gαs, β2AR couples 
to the inhibitory subunit Gαi in cardiac myocytes (195). β2AR can also 
signal in a G protein-independent manner: binding of arrestin to β2AR 
triggers MAP kinase pathways (196, 197). Additionally, desensitization of 
β2AR involves multiple pathways that include phosphorylation of the 
receptor, arrestin-mediated internalization into endosomes, recycling of 
the receptor and lysosomal degradation (198, 199) (Figure 3.1). Finally, 
these activities are further complicated by oligomerization of GPCRs 
(200) and localization to specific membrane compartments (201), which 
results in differences in the composition of the lipid bilayer. Drugs can 
preferentially activate or inhibit these different signaling pathways. This 
shows that the functional behavior of GPCRs is highly complex and 
multifaceted. 
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Figure 3.1: Signal transduction pathways induced by β2AR. A multitude of 
signaling pathways are regulated by β2AR. The receptor can activate two G proteins (Gs 
and Gi). Both G proteins differentially regulate adenylate cyclase. Adenylate cyclase 
generates cyclic AMP (cAMP), a second messenger, which activates protein kinase A 
(PKA). PKA regulates the activity of several cellular proteins, for example the L-type 
Ca2+ channel and also β2AR itself. Specific phosphodiesterase proteins (PDEs) 
downregulate cAMP levels. Activation of β2AR further leads to phosphorylation of β2AR 
by a G protein-coupled receptor kinase (GRK) followed by coupling of arrestin, a 
signaling and regulatory protein. Arrestin promotes the activation of extracellular 
signal-regulated kinases (ERK). Moreover, it prevents the activation of G proteins and 
stimulates internalization of the receptor via clathrin-mediated endocytosis. Protein 
kinase C (PKC) is another protein that can phosphorylate the receptor. Adapted from 
(180). 
3.1.2 Cholesterol and GPCRs 
Cellular membranes functionally modulate a large number of 
membrane proteins (16, 202-206). Such functional modulation is 
facilitated by chemical and physical interactions between membrane 
proteins and phopholipids, sphingolipids, cholesterol and other molecular 
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components of the cell membrane. Similar to many other membrane 
proteins, GPCRs are regulated by their hetero- and homooligomeric 
assembly and the membrane composition. Because the heterogeneous 
composition of cellular membranes changes dynamically, the functional 
state of GPCRs depends on the location in the cell membrane and on the 
state of the cell (207, 208). The steroid cholesterol modulates chemical 
and physical properties of cellular membranes and plays a role in the 
dynamic formation of sphingolipid-enriched assemblies of lipids and 
membrane proteins. These metastable assemblies, or lipid rafts, can 
functionally regulate membrane proteins by different mechanisms (207). 
Indirect regulation of membrane proteins, including GPCRs, can be 
observed through the ability of cholesterol to modulate biophysical 
properties of a lipid bilayer (14) whereas the direct regulation of 
membrane proteins can occur through specific interactions (209-212). 
Although it is not completely understood how cells control the 
distribution of cholesterol and by which mechanisms cholesterol 
functionally regulates GPCRs, insights into these processes are of cell 
biological and pharmacological importance (213, 214). 
Similar to other GPCRs cholesterol modulates the physiological 
function of β2AR (213, 215). Furthermore, cholesterol and the more water-
soluble cholesterol analog cholesteryl hemisuccinate (CHS) enhance the 
thermal stability of β2AR (213, 216). Additionally, cholesterol facilitates 
interactions between GPCRs and appears helpful to crystallize β2AR (65). 
A recently published X-ray crystallography model of human β2AR showed 
cholesterol to fit into a shallow surface groove formed by transmembrane 
α-helices H1, H2, H3 and H4 (217). This structural model unraveled 
possible interactions between cholesterol and β2AR. However, to 
understand to which extent the interactions established by cholesterol 
change kinetic, energetic, and mechanical properties of structural regions 
in the receptor requires additional insight. 
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3.1.3 Ligands and their efficacy profiles 
What are the biophysical mechanisms behind the complex 
functional behavior of GPCRs? The biochemical and biophysical 
properties of GPCRs can be modulated in a ligand-specific manner (218). 
Ligands are classified by their efficacy. The efficacy of a ligand reflects its 
effect on the structure and biophysical properties of a receptor. 
Depending on the biological response, ligands can be grouped into 
different efficacy classes (Figure 3.2). Full agonists are able to 
maximally stimulate the receptor, whereas partial agonists are unable to 
elicit full activity, even at saturating concentrations. Neutral antagonists 
can prevent other ligands from binding to the receptor, but they have no 
effect on signaling activity. Inverse agonists decrease the level of agonist-
independent basal activity. 
 
Figure 3.2: Classification of 
ligand efficacy for GPCRs. Many 
GPCRs exhibit basal or constitutive 
activity, which is independent from 
agonists (red line). Inverse agonists 
inhibit basal activity, whereas 
neutral antagonists have no effect. 
Agonists (and partial agonists) 
initiate biological responses above 
the basal activity. Note that efficacy 
is not directly related to affinity. 
The wide spectrum of ligand efficacies for GPCRs implies that 
efficient energy transfer between the binding pocket and G protein 
binding site depends on multiple interactions between receptor and 
ligand. Apparently, the energy transfer requires more than simply 
occupying the ligand-binding site. Biophysical studies on fluorescently 
labeled β2AR showed that full and partial agonists with different subsets 
of functional groups stabilize distinct conformational states of the 
receptor (219-221). These findings led to a complex picture of GPCR 
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activation: a distinct conformation stabilized by the structure of a ligand 
determines the efficacy towards a specific pathway. Many GPCRs are 
capable of activating multiple signaling pathways (see section 3.1.1), and 
specific ligands can have a different relative efficacy to different 
pathways (222). Even opposite activities for different signaling pathways 
are observed: for β2AR, agonists that induce the arrestin/MAP kinase 
pathway can also act as inverse agonists for the classical Gαs/cAMP/PKA 
pathway (196, 223). Thus, GPCRs are no longer thought to act like simple 
two-state switches. By now, they are regarded as molecular rheostats, 
having the ability to sample a continuum of conformations with relatively 
closely spaced energies (224). There is evidence from biochemical and 
biophysical data showing that GPRCs are flexible and dynamic molecules 
and that functionally distinct ligands can stabilize specific conformations 
of the receptor (224). 
In the following sections, it was investigated how these 
conformations, or interactions, change their dynamic energy profile. For 
that purpose, the dynamic energy landscape of β2AR was determined 
using DFS. Finally, it was investigated how physiologically relevant 
variables, such as cholesterol and ligands, modulate the energy landscape 
of β2AR. 
3.2 Experimental procedures 
3.2.1 Preparation of β2AR proteoliposomes 
β2AR-containing proteoliposomes were kindly provided by Brian 
Kobilka (Stanford University). Spodoptera frugiperda (Sf9) insect cells 
were grown at 27°C in suspension cultures in ESF-921 medium 
(Expression Systems, USA) supplemented with 0.5 mg/ml gentamicin. 
The Bac-to-Bac® Baculovirus Expression System (Invitrogen, USA) was 
used for generating baculovirus for the β2AR. Throughout this project, a 
modified construct of human β2AR with a truncated C-terminal end (48 
amino acids (aa)) and a N-terminal FLAG epitope followed by a TEV 
protease cleavage site was used. β2AR expression was accomplished by 
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infecting Sf9 cells at a density of ≈3 x 106 cells/ml for ≈48 h. Cells 
expressing receptors, as assessed by immunofluorescence, were harvested 
by centrifugation (15 min at 5000g). Cell pellets were stored at -80 °C. 
From these pellets β2AR was purified using a three-step purification 
procedure as described (225). For preparation of lipids, 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) (Avanti Polar Lipids, USA) and the 
cholesterol analog cholesteryl hemisuccinate (CHS) (Steraloids, USA) 
were mixed and dissolved in chloroform to form a stock solution of lipids 
at concentrations of 20 mg/ml and 10 mg/ml. DOPC and CHS were added 
to a glass vial, with DOPC at a 10-fold excess, and the chloroform was 
evaporated under a fine stream of argon. To prepare DOPC lipids without 
cholesterol, CHS was excluded from all preparation steps. The lipids were 
then dried under vacuum for 1 h. After this, the lipids were resuspended 
in 100 mM NaCl, 1% (w/v) octylclucoside, 20 mM HEPES, pH 7.5, 
vortexed and sonicated for 1 h in an ice water bath. The lipid mixture was 
stored at -80°C.  
β2AR was reconstituted as described previously (225). Briefly, 300 
µl samples were prepared containing lipid and the β2AR at a lipid-to-
receptor ratio of 1,000:1 (mol:mol). The lipid/receptor mixture was mixed 
with reconstitution buffer (100 mM NaCl, 20 mM HEPES, pH 7.5) at a 
final volume of 300 µl and placed on ice for 2 h. Vesicles were formed 
removing detergent on a Sephadex G-50 (fine) column (25 x 0.8 cm) using 
reconstitution buffer. To bind ligands, β2AR in DOPC/CHS liposomes was 
pre-incubated for 1 h at room temperature (≈22°C) with saturating 
amounts (10 µM for BI-167107 (BI, Boehringer-Ingelheim), THRX-144877 
(THRX, Theravance) and carazolol, 100 µM for alprenolol and 100 µM for 
adrenalin). During subsequent reconstitution steps, the same 
concentration of ligand was included in the reconstitution buffer. 
3.2.2 SMFS and DFS 
SMFS was conducted using two different AFMs that provided 
similar results (ForceRobot 300, JPK Instruments, Germany and 
Nanoscope IIIa PicoForce AFM, Bruker, Germany). SMFS data of β2AR 
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were recorded at pulling velocities of 100, 300, 600, 900, 1200, 2500 and 
5000 nm/s. SMFS at pulling velocity of 5000 nm/sec was recorded using 
an additional 16-bit data acquisition hardware (Nanoscope IIIa: NI PCI-
6221; ForceRobot 300: NI PCI-6251, National Instruments, Germany). 
Cantilevers used (60 µm long silicon nitride A-BioLever, BL-RC150 VB, 
Olympus Ltd., Japan) had nominal resonance frequencies of ≈8 kHz in 
water. Cantilever spring constants (≈30 pN/nm) were determined in 
buffer solution using the equipartition theorem (226, 227) prior to 
experiments. Due to uncertainties in calibrating the cantilever spring 
constant (≈10%), β2AR was unfolded using at least five different 
cantilevers for each velocity. Proteoliposomes containing β2AR were 
adsorbed over night at 4˚C onto freshly cleaved mica in SMFS buffer (300 
mM NaCl, 25 mM MgCl2, 25 mM Tris, pH 7.0). Mica is an atomically flat, 
chemically inert and hydrophilic surface, which so far did not 
significantly influence the structure-function relationship of membrane 
proteins and their interactions probed by SMFS (93, 123, 138, 156). To 
remove weakly attached membrane patches, the sample was rinsed 
several times with SMFS buffer. SMFS buffer solutions were prepared 
using nanopure water (≥18 MOhm/cm; PURE-LAB Ultra, ELGA 
LabWater) and pro-analysis grade (≥98.5%) chemicals from Sigma-
Aldrich or Merck. All SMFS experiments were performed under identical 
SMFS buffer conditions at 24°C. To characterize ligand binding, SMFS 
buffer was supplemented with adequate amounts of the ligand. To attach 
a single β2AR via unspecific interactions, the AFM stylus was pushed 
onto proteoliposomes, applying a constant force of 700 pN for 0.5 s. The 
unspecific attachment between AFM stylus and terminal end of the β2AR 
polypeptide chain is strong enough to withstand pulling forces of ≈2 nN 
(93, 228). Separation of stylus and membrane stretched the polypeptide 
and exerted a force at the protein. At sufficiently high pulling force β2AR 
unfolded stepwise. Unfolding events were monitored recording the 
cantilever deflection and the distance separating cantilever stylus and 
membrane. Interaction forces were calculated from the cantilever 
deflection using Hook’s law. 
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3.2.3 Data selection 
Mechanical unfolding of β2AR was recorded by F-D curves. Each 
force peak of a F-D curve denoted the rupture of an unfolding barrier 
established by a structural segment of β2AR. The distance at which a 
force peak was detected assigned the contour length of the unfolded and 
stretched polypeptide that tethered the AFM stylus and the anchoring 
structural segment. The very last force peak of a F-D curve represented 
the unfolding of the last structural segment remaining anchored by the 
lipid bilayer (159). Overcoming the stability of this last segment lead to 
complete unfolding of the receptor, followed by extraction from the 
membrane. In the GPCR bovine rhodopsin, the last structural segment 
(or unfolding barrier) corresponds to α-helix H8, which lies parallel to the 
membrane bilayer followed by a palmitoylation site (229). It was assumed 
that this was also the case for β2AR since it shares very similar structural 
features with rhodopsin. A fully stretched β2AR polypeptide that remains 
anchored by α-helix H8 would show a contour length of ≈260 to 290 aa. 
Therefore, F-D curves showing a maximum length of 70-90 nm (≈260 to 
290 aa) were selected for data analysis. 
3.2.4 Data analysis 
Every force peak of a F-D curve was fitted using the WLC model 
(161) (see section 2.8.2). A persistence length P of 0.4 nm and a backbone 
length of 0.36 nm were assumed for every aa. The contour length !! (in 
aa) obtained from fitting a force peak using the WLC model describes the 
length of the polypeptide that had been unfolded and stretched. Contour 
lengths and rupture forces were statistically analyzed for every 
reproducibly occurring force peak using built-in and custom procedures of 
IgorPro 6 (WaveMetrics, USA). To generate density maps, F-D curves 
were superimposed and aligned to the characteristic force peak detected 
at the contour length of 121 aa. 
3.2.5 Assignment of stable structural segments 
The contour length determined by the WLC fits corresponds to the 
length of the unfolded and stretched β2AR polypeptide that tethers AFM 
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stylus and a structural unfolding intermediate. Thus, every force peak 
could be used to assign the end of the previous and the beginning of the 
following structural segment that stabilized β2AR against unfolding (125). 
Some stable structural segments had to be assumed to begin at the 
cytoplasmic β2AR surface at the opposite side of the pulling AFM stylus. 
To locate the beginning of such a stable structural segment, the so-called 
‘membrane compensation procedure’ was applied (125, 159). Thereto, the 
thickness of the membrane (≈4 nm) was added to the contour length of 
the corresponding force peak (125, 159). Accordingly, ≈11 aa (11 aa  0.36 
nm/aa) were added to the contour length of a force peak. If the beginning 
of a stable structural segment was located within the membrane, less aa 
were added to the contour length.  
3.2.6 Calculation of !! and !! 
The Bell-Evans theory (177) describes the most probable unfolding 
force !∗ as a function of the most probable loading rate rf* to reveal 
insight into the unfolding energy barrier that stabilizes a structural 
segment against unfolding (171) (see section 2.8.3). Using a non-linear 
least squares algorithm, the parameters !!  and !!  were obtained by 
fitting Equation 2.8 to a DFS plot. The loading rate was calculated using !! = !!"#$%&   ! , where !!"#$%&  is the spring constant of the stretched 
polypeptide and ! is the pulling velocity. !!"#$!" corresponds to the slope 
of a force peak before rupture. Experimental force and loading rate 
histograms were fitted using Gaussian distributions. 
3.2.7 Calculation of transition barrier height and rigidity 
The free energy barrier ∆!!‡  separating the unfolded from the 
folded state was calculated using Equation 2.9. In the calculations, !! = 
10-8 s was used. Varying !! in the range mentioned in section 2.8.3 would 
change ∆!!‡ by <15%. Furthermore, the influence of errors of !! would be 
the same for all conditions and ∆!!‡ values, even if !! was wrong by orders 
of magnitude. Errors in ∆!!‡ were calculated by propagation of errors of !!. Without having information on the energy potential shape, a simple 
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parabolic potential was assumed. The mechanical spring constant  ! of a 
structural segment was calculated using ∆!!‡  and !!  (230) with the 
following equation: 
! = 2∆!!‡!!!  Equation 3.1 
To estimate errors in !, errors in ∆!!‡ and !! were propagated. 
3.3 Cholesterol dependent interactions of β2AR 
3.3.1 Results 
3.3.1.1 SFMS of human β2AR in the presence and absence of 
cholesterol 
To characterize the influence of cholesterol on the interactions 
stabilizing human β2AR, the receptor was reconstituted into liposomes 
containing phospholipids (DOPC) or phospholipids and cholesteryl 
hemisuccinate (DOPC/CHS) (see section 3.2.1). For SMFS, β2AR the 
proteoliposomes were densely adsorbed onto freshly cleaved mica (Figure 
3.3). The AFM stylus was pushed onto the proteoliposomes with a force of 
≈700 pN for 0.5 s (Figure 3.4A). Subsequently, the cantilever was 
retracted, and its deflection recorded as a force-distance (F-D) curve. In 
≈0.5% of these approach-and-retract cycles, a single β2AR attached to the 
AFM stylus and the F-D curve recorded during retracting the cantilever 
showed a sawtooth-like pattern with several force peaks. These sawtooth-
like patterns were similar for β2AR reconstituted in DOPC (Figure 3.4B, 
top) and DOPC/CHS liposomes (Figure 3.4C, top). Each force peak of a 
F-D curve reflected the unfolding of a structural segment of β2AR. The 
magnitude of the force peak revealed the strength of the interaction that 
stabilized a structural segment against unfolding. These interactions 
were composed of inter- and intramolecular interactions. For analysis 
only F-D curves with an overall length of ≈70-90 nm were selected, since 
they describe the complete unfolding of the receptor from its terminus 
(see section 3.2.3). To highlight common features among the F-D curves, 
they were superimposed and displayed as density plots (Figure 3.4B,C, 
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bottom). The superimpositions of F-D curves recorded of β2AR 
reconstituted in DOPC (Figure 3.4B) and DOPC/CHS (Figure 3.4C) 
showed a characteristic pattern of eight force peaks. The presence of 
cholesterol did not change the position of the force peaks. However, the 
magnitude of the force peaks increased in presence of cholesterol (Figure 
3.5). This difference implies that cholesterol increases the strength of 
interactions stabilizing β2AR. 
 
Figure 3.3: AFM deflection image of β2AR 
proteoliposomes. Proteoliposomes were 
adsorbed over night at 4˚C onto freshly cleaved 
mica in buffer solution (300 mM NaCl, 25 mM 
MgCl2, 25 mM Tris, pH 7.0). To remove weakly 
attached membrane patches, the sample was 
rinsed several times with the same buffer 
solution. The contact mode AFM deflection 
image was recorded in buffer solution applying 
an imaging force of ≈50-100 pN. 
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Figure 3.4: SMFS of β2AR reconstituted into liposomes composed of either 
phospholipids (DOPC) or phospholipids and cholesterol (DOPC/CHS). (A) 
Pressing the AFM stylus onto the proteoliposomes promotes the unspecific attachment 
of a single β2AR polypeptide to the stylus. Withdrawal of the AFM cantilever stretches 
the polypeptide and induces the sequential unfolding of β2AR. F: force, d: distance. (B, 
C) Selection of force-distance (F-D) curves recorded upon N-terminal unfolding of β2AR 
reconstituted into DOPC (B, top) and DOPC/CHS liposomes (C, top). Density plots of 
superimposed F-D curves (bottom of (B) and (C)) highlight their common features. 
Number of superimposed F-D curves n=100 (B) and n=100 (C). Red numbers on top of 
each WLC curve (red dashed lines) indicate the average contour lengths (in amino acids) 
revealed from fitting each force peak of each superimposed F-D curve. Gray scale bars 
allow evaluating how frequently individual force peaks were populated. 
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Figure 3.5: Average force required to unfold structural segments of β2AR 
reconstituted into liposomes composed of phospholipids (DOPC) or of 
phospholipids and cholesterol (DOPC/CHS). (A) On average the force required to 
unfold β2AR reconstituted into DOPC/CHS liposomes (black) was higher than the 
average force required to unfold β2AR reconstituted into DOPC liposomes (red). This 
difference implies an increased mechanical stability of the GPCR in the presence of 
cholesterol. To determine average unfolding forces the sum of unfolding forces detected 
for every peak of every force-distance spectrum used in superimpositions shown in 
Figure 3.4B and Figure 3.4C was calculated. This sum of forces was then divided by 
the number of all analyzed F-D curves. (B) To exclude that differences in average forces 
are not a result of cantilever calibration errors, β2AR in DOPC (red) and DOPC/CHS 
(black) liposomes was unfolded under identical experimental conditions using the same 
cantilever. Bin sizes of histograms are 3 aa. The pulling velocity was 300 nm/s (A) and 
528 nm/s (B). The numbers (n) of analyzed F-D curves are indicated. 
3.3.1.2 Unfolding β2AR from N- and C-terminal ends 
In principle β2AR could attach non-specifically with either the N- 
or the C-terminal end to the AFM stylus. Accordingly, two different 
unfolding F-D spectra were recorded (Figure 3.6). To assign these classes 
to N- or C-terminal unfolding, the N-terminal FLAG tag was 
enzymatically removed and the shortened β2AR was unfolded (Figure 
3.7). A shift of ≈14 aa was observed in one class of F-D curves, suggesting 
that this particular class corresponds to N-terminal unfolding. 
Approximately 75% of the F-D curves (n≈1000) corresponded to unfolding 
of β2AR by mechanically pulling the N-terminal end (Figure 3.6A). The 
remaining F-D curves represented unfolding the receptor from the C-
terminal end (Figure 3.6B). The superimpositions of F-D curves showed 
a characteristic pattern of eight force peaks when unfolding β2AR from 
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the N-terminal end (Figure 3.6A, bottom). When unfolding β2AR from 
the C-terminal end, only four reproducible force peaks were detected 
(Figure 3.6B, bottom). The C-terminal region of the receptor, which is 
unfolded at pulling distances <30 nm, did not reveal reproducible 
unfolding events (force peaks) (Figure 3.6B). In summary, F-D curves 
recording the unfolding of β2AR from the N-terminal end occurred at 
higher probability and, most importantly, detected more unfolding events 
and interactions of the GPCR. For these reasons, only F-D curves that 
were recorded upon unfolding of β2AR from the N-terminus were 
analyzed. 
 
Figure 3.6: N- and C-terminal unfolding of β2AR reconstituted into DOPC/CHS 
liposomes. Selection of force-distance (F-D) curves recorded upon N-terminal (A, top) 
and C-terminal (B, top) unfolding of β2AR. Superimpositions of F-D curves (density plots 
at bottom of (A) and (B) highlight their common features. Red dashed lines represent 
WLC fits of the force peaks and the numbers on top of the curves indicate the average 
contour lengths (in amino acids) revealed from the WLC fits. Gray scale bars allow 
evaluating how frequently individual force peaks were populated. SMFS data recorded 
in SMFS buffer (300 mM NaCl, 25 mM Tris, 25 mM MgCl2, pH 7.0). Number of 
superimposed F-D curves n=103 (A, bottom) and n=56 (B, bottom). 
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Figure 3.7: Unfolding β2AR after removal of the FLAG-Tag. (A) Secondary 
structure model of 365N β2AR with N-terminal FLAG tag followed by a TEV protease 
cleavage site (colored in green). Superimposition of F-D curves recorded pulling N-
terminal (B) and C-terminal (C) ends before TEV protease treatment. SMFS of the 
untreated receptor shows the normal full-length spectrum. Force peaks were fitted using 
the WLC model to reveal the contour length of the unfolded and stretched polypeptide 
(given at the end of each WLC fit in aa). (D) Treatment of β2AR with TEV protease (red 
triangle) and PNGase F (blue triangles) removed 14 amino acids (aa) from the N-
terminus and the glycosylations, respectively. (E) Superimposition of F-D curves 
recorded pulling the truncated N-terminal end of β2AR after TEV protease treatment. 
On average the force peaks showed a shift of 14 aa. (F) Superimposition of F-D curves 
recorded pulling the C-terminal end of TEV protease treated β2AR. The superimposition 
shows the spectrum of the untreated receptor. Data (B-F) recorded in buffer solution 
(300 mM NaCl, 25 mM MgCl2, 25 mM Tris, pH 7.0). (G) Bimane fluorescence and 
Coomassie stain of untreated, TEV protease and PNGase F treated bimane labeled 
β2AR. The molecular weight was shifted on the gel after treatment with TEV, PNGaseF 
and both enzymes. 
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3.3.1.3 Mapping interactions that stabilize structural segments of 
β2AR 
After having identified that the superimposed F-D spectra (Figure 
3.4B,C, bottom) correspond to the unfolding of β2AR from the N-terminal 
end (see previous section) the interactions were mapped to the β2AR 
structure. When exerting sufficient force to the N-terminal end, β2AR 
unfolds in a sequence of steps. Every force peak of the F-D curve reflects 
an unfolding step (Figure 3.4B,C, top). An unfolding step, in which a 
structural segment unfolds, describes the transfer of one unfolding 
intermediate to the next (125). To assign the unfolding steps and 
structural segments, every force peak of a F-D curve was fitted using the 
worm-like chain (WLC) model (see section 2.8.2). Each WLC fit revealed 
the contour length of the unfolded polypeptide that connected AFM stylus 
and the unfolding intermediate of the receptor. The contour lengths of all 
force peaks allowed determining all unfolding steps of β2AR (Figure 
3.4B,C, Table 3.1). In the first unfolding step the N-terminus and the N-
terminal transmembrane α-helix of β2AR unfolded. Next, the unfolded 
polypeptide linking AFM stylus and the stable structural segments that 
remained folded and anchored in the membrane was elongated and 
stretched. As soon as the stretching force exceeded the stability of the 
next structural segment this segment unfolded as well. This sequential 
unfolding of one structural segment after the other continued until the 
entire β2AR had been unfolded. In summary, eight unfolding steps were 
detected, each step reflecting the unfolding of a structural segment. 
Mapped onto the secondary and tertiary structure these stable structural 
segments show where inter- and intramolecular interactions stabilized 
β2AR (Figure 3.8). Because the common unfolding peaks detected for 
β2AR in the presence and in the absence of cholesterol showed no 
differences in their position (Figure 3.4), it could be concluded that 
cholesterol did not stabilize different structural segments (Figure 3.8). 
However, apparently the strength of the interactions stabilizing β2AR 
depended on the presence of cholesterol (Figure 3.5). In the following the 
nature of these interactions was investigated. 
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Table 3.1: Mean contour lengths of force peaks in F-D curves recorded during 
N-terminal unfolding of β2AR and stable structural segments assigned to the 
force peaks. Contour lengths represent mean peak positions. Errors represent 
standard deviations (SD). Number of analyzed F-D curves n=100 (DOPC) and n=100 
(DOPC/CHS). 
Stable structural segment 
Contour length ± SD (aa) 
DOPC DOPC/CHS 
[H1.1] 49 ± 4 49 ± 4 
[H1.2-C1] 58 ± 4 58 ± 3 
[H2.1] 73 ± 3 73 ± 3 
[H2.2-E1] 88 ± 4 88 ± 4 
[H3-C2-H4-E2-H5.1] 121 ± 0 121 ± 0 
[H5.2-C3-H6.1] 135 ± 9 135 ± 7 
[H6.2-E3-H7-H8] 195 ± 8 195 ± 7 
[CT] 275 ± 13 275 ± 11 
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Figure 3.8: Structural segments stabilizing human β2AR. Secondary (A) and 
tertiary (B) structure model of β2AR. Each color represents a structural segment that is 
stabilized by inter- and intramolecular interactions. (A) Black amino acids (aa) highlight 
the end of the previous and the beginning of the next stable structural segment. This 
structural position corresponds to the mean contour length (given in brackets) revealed 
from WLC curves fitting every force peak of every F-D curve. aa colored at less intensity 
give the standard deviation of locating the average force peak (Table 3.1). Membrane 
compensation’ (see section 3.2.5) was applied for the boundaries of structural segments 
that had to be assumed to lie within the membrane or at the membrane surface opposite 
to the puling AFM stylus. All seven transmembrane α-helices of β2AR are labeled with 
bold numerals (H1-H7). Cytoplasmic and extracellular loops are indicated C1, C2, C3 
and E1, E2, E3, respectively. H8 denotes the short C-terminal α-helix 8 at the 
cytoplasmic side. The secondary structure model (A) of C-terminally truncated β2AR 
carrying a N-terminal FLAG epitope (blue) followed by a TEV protease cleavage site 
(green) was taken from (66). The tertiary structure model (B) was taken from PDB ID 
3D4S. 
3.3.1.4 Cholesterol changes the energy landscape of β2AR 
The most probable force required to unfold a structural segment of 
a protein depends on the loading rate (pulling force applied versus time) 
(165). Thus, the unfolding force is only a relative measure of the stability 
of a structural segment exposed to mechanical stress. However, the 
kinetic, energetic, and mechanical properties of a folded structure that 
resides in an energy valley at equilibrium can be described by a free 
energy unfolding landscape (Figure 2.3). To approximate these 
parameters (165, 231) F-D curves were recorded at seven different pulling 
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velocities (100, 300, 600, 900, 1200, 2500 and 5000 nm/s). To investigate 
the effect of cholesterol on the energy landscape of β2AR, DFS was carried 
out in the absence and in the presence of cholesterol. Then the most 
probable unfolding force !∗ of every structural segment was determined 
at different loading rates !!∗. After this, the most probable unfolding force 
was plotted versus the most probable loading rate for every structural 
segment in a so-called DFS plot (Figure 3.9). As theoretically predicted 
(171, 177) and experimentally verified using membrane proteins (129, 
130, 135, 232-234), increasing the loading rate increased the unfolding 
forces. A linear relationship between the most probable unfolding force 
and the logarithm of the loading rate was observed for every interaction. 
This linearity suggests that, for every structural segment, a single energy 
barrier separated the folded from the unfolded state (Figure 2.3) (171). 
The DFS data were fitted using Equation 2.8 (Figure 3.9) to reveal the 
ground-to-transition-state distance !!  and transition rate !! , and 
Equation 2.9 and Equation 3.1 were used to estimate the unfolding free 
energy ∆!!‡  and the mechanical spring constant !  for every structural 
segment of β2AR (see section 2.8.3). The statistical significance of these 
differences was estimated using a non-linear sum-of-squares F-test 
(Table 3.2) (235, 236). Several segments showed statistical significant 
differences in the presence of cholesterol (Table 3.3) suggesting that the 
energy barriers stabilizing the individual structural regions of β2AR 
changed. In the following these cholesterol-induced changes will be 
described. 
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Figure 3.9: Loading rate dependent interactions stabilizing structural 
segments of β2AR depend on cholesterol. DFS plots of each structural segment of 
β2AR reconstituted into DOPC (red) and DOPC/CHS liposomes (black). Shown is the 
most probable unfolding force against the most probable loading rate. Solid lines show 
DFS fits from which !!  and !!  were obtained (Table 3.3). Error bars indicate the 
standard error of the most probable force and the loading rate. 
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Table 3.2: Sum of squares F-test comparing DFS data recorded from β2AR 
reconstituted into DOPC and DOPC/CHS liposomes. For every stable structural 
segment the DFS data points (Figure 3.9) were fitted individually and simultaneously 
using Equation 2.8. The difference between the individually and simultaneously fitted 
values was assessed by sum-of-square (SSQ) F-tests. Degrees of freedom (dof) are given 
in parentheses. The F-ratio given by F=((SSQ1-SSQ2)/(dof1-dof2))/(SSQ2/dof2) 
quantifies the relationship between the relative increase in the sum of squares and the 
relative increase in the degrees of freedom. SSQ1 and SSQ2 refer to the sum of the two 
compared fits; dof1 and dof2 denote the degrees of freedom of the two compared fits. p-
values estimate the significance of differences of the same stable structural segment 
detected in β2AR in DOPC/CHS and DOPC. 
Lipid Stable 
structural 
segment 
Separate 
SSQ1 (dof1) 
SSQ2 (dof2) 
Common 
SSQ (dof) 
F-ratio p-value 
DOPC/CHS 
[H1] 
154.1 (5) 
1477.8 (12) 21.110 1.20210-4 
DOPC 128.9 (5) 
DOPC/CHS 
[H1.2-C1] 
214.0 (5) 
860.8 (12) 7.490 6.46410-3 
DOPC 130.6 (5) 
DOPC/CHS 
[H2.1] 
253.7 (5) 
1083.1 (12) 9.609 2.71810-3 
DOPC 117.0 (5) 
DOPC/CHS 
[H2.2-E1] 
164.5 (5) 
1016.7 (12) 12.028 1.17910-3 
DOPC 134.0 (5) 
DOPC/CHS 
[H3-C2-H4-E2-H5.1] 
24.0 (5) 
89.6 (12) 0.657 0.597 
DOPC 55.2 (5) 
DOPC/CHS 
[H5.2-C3-H6.1] 
497.7 (5) 
4581.7 (12) 26.153 4.75610-5 
DOPC 237.6 (5) 
DOPC/CHS 
[H6.2-E3-H7-H8] 
138.9 (5) 
596.4 (12) 14.606 5.51210-4 
DOPC 13.2 (5) 
DOPC/CHS 
[CT] 
90.6 (5) 
659.3 (12) 18.546 2.07610-4 
DOPC 49.4 (5) 
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Table 3.3: Parameters characterizing the free energy barrier (!!, !! and ∆!!‡) 
and spring constant (!) of structural segments stabilizing β2AR reconstituted 
into DOPC and DOPC/CHS liposomes. Errors represent standard deviations (SD). 
Differences were considered significant when p-values approached p < 0.001 from F-
tests (Table 3.2) and their changes did not overlap with their standard deviation. 
Significant changes are highlighted bold. 
Stable structural segment 
!! ± SD (nm) !! ± SD (s-1) 
DOPC DOPC/CHS DOPC DOPC/CHS 
[H1.1] 0.33 ± 0.02 0.44 ± 0.04 3.935 ± 1.210 0.077 ± 0.073 
[H1.2-C1] 0.26 ± 0.02 0.29 ± 0.02 1.418 ± 0.429 0.248 ± 0.178 
[H2.1] 0.32 ± 0.02 0.33 ± 0.02 1.250 ± 0.496 0.290 ± 0.174 
[H2.2-E1] 0.37 ± 0.02 0.45 ± 0.05 2.174 ± 0.592 0.166 ± 0.140 
[H3-C2-H4-E2-H5.1] 0.55 ± 0.04 0.55 ± 0.03 0.055 ± 0.041 0.038 ± 0.022 
[H5.2-C3-H6.1] 0.26 ± 0.01 0.29 ± 0.02 0.443 ± 0.162 0.018 ± 0.014 
[H6.2-E3-H7-H8] 0.45 ± 0.03 0.49 ± 0.03 1.376 ± 0.384 0.320 ± 0.118 
[CT] 0.54 ± 0.03 0.59 ± 0.05 0.126 ± 0.054 0.011 ± 0.008 
 
Stable structural segment 
∆!!‡ ± SD (!!!) !± SD (N/m) 
DOPC DOPC/CHS DOPC DOPC/CHS 
[H1.1] 17.1 ± 0.3 21.0 ± 0.9  1.26 ± 0.11 0.88 ± 0.13 
[H1.2-C1] 18.1 ± 0.3 19.8 ± 0.7 2.39 ± 0.17 2.02 ± 0.26 
[H2.1] 18.2 ± 0.4 19.7 ± 0.6 1.51 ± 0.17 1.49 ± 0.18 
[H2.2-E1] 17.6 ± 0.3 20.2 ± 0.8 1.07 ± 0.10 0.84 ± 0.15 
[H3-C2-H4-E2-H5.1] 21.3 ± 0.7 21.7 ± 0.6 0.58 ± 0.07 0.59 ± 0.06 
[H5.2-C3-H6.1] 19.2 ± 0.4 22.4 ± 0.8 2.43 ± 0.21 2.23 ± 0.25 
[H6.2-E3-H7-H8] 18.1 ± 0.3 19.6 ± 0.4 0.73 ± 0.08 0.69 ± 0.08 
[CT] 20.5 ± 0.4 23.0 ± 0.7 0.59 ± 0.06 0.54 ± 0.06 
3.3.1.5 Cholesterol increases kinetic and energetic stability of 
β2AR 
Most prominent among the changes induced by cholesterol is that 
almost every structural segment of β2AR increased kinetic and energetic 
stability (Table 3.3). The free energy barriers that stabilize each 
structural segment against unfolding increased height in the presence of 
cholesterol. Particular the energy barriers stabilizing the structural 
segments [H1.1], [H1.2-C1], [H2.1], [H2.2-E1], [H5.2-C3-H6.1], [H6.2-E3-
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H7-H8] and [CT] were significantly higher in the presence of cholesterol. 
For individual structural segments the free energy increase caused by 
cholesterol ranged between 1.5 !!! ([H2.1] and [H6.2-E3-H7-H8]) and 
3.9 !!! ([H1.1]). The exception was the largest structural segment [H3-
C2-H4-E2-H5.1], whose small increase of the energy barrier (0.4 !!!) was 
not significant. Synchronous to the free energy barrier heights, the 
structural segments significantly increased kinetic stability (reciprocal of 
the transition rate !!) in the presence of cholesterol (Table 3.3). Some 
structural segments increased their kinetic stability considerably. For 
example in the presence of cholesterol structural segment [H1.1] 
increased kinetic stability by a factor of 50, [H1.2-C1] by a factor of 6, 
[H2.1] and [H6.2-E3-H7-H8] by a factor of 4, [H5.2-C3-H6.1] by a factor of 
25, and [CT] by a factor of 11. However, the transition rate of the 
structural core segment [H3-C2-H4-E2-H5.1] remained unchanged in the 
presence of cholesterol. 
3.3.1.6 Cholesterol increases conformational variability and 
decreases mechanical rigidity of transmembrane α-helices 
H1 and H2 
The conformational variability of a structure can be approximated 
by the ground-to-transition state distance !! (237, 238). With increasing 
ground-to-transition state distance the energy valley stabilizing a 
structural segment becomes wider. Consequently, the segment can adopt 
more conformational substates and, therefore, enhances conformational 
variability. On the contrary, if an energy valley stabilizing a structural 
segment narrows the conformational variability of the structural segment 
decreases (Figure 2.3). The only structural segments that significantly 
increased transition state distance !! by ≈20-30% and, thus, increased 
conformational variability were [H1.1] and [H2.2-E1] (Table 3.3). 
Although the other structural segments of β2AR showed similar trends in 
presence of cholesterol these differences were insignificant. 
The spring constant !  quantifies the mechanical rigidity of a 
structural segment (135, 230). Although all structural segments (except 
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[H3-C2-H4-E2-H5.1]) slightly decreased their mechanical rigidity (spring 
constant) in the presence of cholesterol (Table 3.3), this decrease was 
only statistically significant for structural segment [H1.1], which 
decreased the spring constant by ≈30% to 0.88 N/m. 
3.3.2 Discussion 
3.3.2.1 Cholesterol strengthens interactions of almost every 
structural segment of β2AR 
Using SMFS, interactions that stabilize the human β2AR 
reconstituted into DOPC liposomes were characterized. F-D spectra 
recorded during mechanical unfolding of β2AR showed a reproducible 
pattern of force peaks (Figure 3.4B,C). This pattern suggests that a 
characteristic interaction network stabilized structural segments within 
β2AR. The presence of cholesterol did not alter the position of the force 
peaks. Thus, it can be concluded that the interactions established in the 
presence of cholesterol stabilized the same structural segments of β2AR 
as detected in the absence of cholesterol. However, cholesterol increased 
the magnitude of individual force peaks (Figure 3.5) and, thus, increased 
the interaction strengths stabilizing the structural segments within β2AR 
(Figure 3.9). As this trend was observed for all structural segments 
(except for [H3-C2-H4-E2-H5.1]) and for all pulling velocities it can be 
concluded that cholesterol increased the mechanical stability of β2AR. 
This increased mechanical stability may result from direct interactions 
between cholesterol and β2AR. However, since cholesterol also affects the 
properties of the lipid membrane (14, 239, 240) and because cholesterol 
establishes direct interactions with some but not with all structural 
segments of β2AR (217), it can be assumed that it also affected the 
stability of β2AR indirectly. 
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3.3.2.2 Cholesterol increases free energy barrier and kinetic 
stability of every structural segment except for the 
structural core segment 
The strengths of the interactions stabilizing the structural 
segments of β2AR depended on the loading rate (Figure 3.9). This 
dependency was used to characterize the energy valley and barrier 
stabilizing every structural segment (Table 3.3). Except for the 
structural core segment [H3-C2-H4-E2-H5.1], cholesterol significantly 
affected the energy landscape of every structural segment of β2AR. 
Generally, the free energy barriers stabilizing these structural segments 
increased height in the presence of cholesterol. Consequently, the 
structural segments reduced transition rate and increased kinetic 
stability. Thus, cholesterol increased the kinetic and energetic stability of 
β2AR. However, the energy landscape of individual structural segments 
stabilizing β2AR and thus their properties changed quite individually. 
These changes, which are structurally mapped in Figure 3.10, will be 
discussed in the following. 
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Figure 3.10: Mapping the kinetic, energetic, and mechanical properties of β2AR 
in the absence (A) and presence (B) of cholesterol. Structural segments stabilizing 
β2AR (PDB ID code 3D4S are mapped on the left. Transition state distance !!, transition 
rate !!, free energy barrier height ∆!!‡, and spring constant ! of structural segments in 
the absence of cholesterol (A) and in the presence of cholesterol (B). The color of the 
β2AR backbone roughly indicates the value for each parameter as indicated by the scale 
bars. Top panel of (A) and (B) shows β2AR from side view, lower panel of (A) and (B) 
shows β2AR from extracellular view. Values were taken from Table 3.3. 
3.3.2.3 [H1.1] 
The presence of cholesterol affected kinetic, energetic, and 
mechanical parameters of structural segment [H1.1]. Cholesterol 
increased the transition state distance !!  by 33% to 0.44 nm, which 
enhanced the conformational variability of the extracellular region of 
transmembrane α-helix H1. Furthermore, cholesterol significantly 
decreased the transition rate !! and thus, increased the kinetic stability 
of [H1.1] 50-fold. Moreover, cholesterol increased the free energy barrier, 
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∆!!‡, stabilizing [H1.1] by ≈4 !!! (≈23%). Finally, [H1.1] was the only 
structural segment of β2AR, which significantly lowered the spring 
constant ! in presence of cholesterol from 1.26 N/m to 0.88 N/m (≈30%). 
This implies that cholesterol increases mechanical flexibility of this 
structural region. The X-ray structure suggests that H1 establishes a 
direct interaction with cholesterol (217). The DFS data shows that 
cholesterol kinetically and energetically stabilizes the extracellular part 
of α-helix H1 and enhances its mechanical flexibility. It is thought that 
GPCRs including β2AR can assemble into dimers in the plasma 
membrane (200, 241). Although the functional importance of this 
dimerization and the exact location of the dimer interface in GPCRs are 
not fully understood (242) it may be speculated that cholesterol promotes 
β2AR dimerization, since ordered cholesterol molecules were found in the 
interface between H1 and H8 of two symmetry-related β2AR molecules 
(65). It has been proposed for several other class A GPCRs that α-helix 
H1 is involved in receptor oligomerization (243, 244). Therefore, it may be 
speculated that increased kinetic and energetic stability, and mechanical 
flexibility of [H1.1] may favor oligomerization of β2AR. 
3.3.2.4  [H1.2-C1] 
In the presence of cholesterol the energy landscape stabilizing 
structural segment [H1.2-C1] showed minor but statistically significant 
changes. [H1.2-C1] decreased transition rate and, thus, increased kinetic 
stability 6-fold. The free energy of [H1.2-C1] increased by 1.7 !!! (≈9%), 
indicating that this structural segment stabilizes in the presence of 
cholesterol. Structural models show cholesterol binding to the C-terminal 
part of transmembrane α-helix H1 (217), which could directly change the 
properties of structural segments [H1.1] and [H1.2-C1] as detected by 
DFS. Further changes may be caused by direct interactions between 
cholesterol and residue Y70 at the interface between structural segments 
[H1.2-C1] and [H2.1]. The minor changes detected for [H1.2-C1] 
correlates with the finding that Y70 appears to be the least important 
residue for cholesterol binding and establishes only van-der-Waals-
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interactions with ring A of cholesterol (217). In absence of further 
information, it may be speculated that electrostatic interactions between 
hydrophilic residues of intracellular loop C1 (e.g. K60, R63) and the 
cholesterol hydroxyl group could also contribute to the cholesterol-
induced changes of [H1.2-C1]. 
3.3.2.5 [H2.1] 
Cholesterol reduced the transition rate !!  of [H2.1] 6-fold and 
increased the height of the free energy barrier ∆!!‡ by 1.5 !!! (≈8%). The 
ground-to-transition state distance !! and the spring constant ! of [H2.1] 
remained unchanged. Thus, in the presence of cholesterol, the lifetime 
and the energetic stability of [H2.1] enhanced significantly. These 
changes may result from direct interactions between β2AR and 
cholesterol, which interacts with [H2.1] via residues T73, S74 and C77 
(217). Hanson et al. (217) showed that cholesterol increases the packing 
value for transmembrane α-helix H2, which correlates with an increased 
thermal stability of β2AR. The DFS data shows that the increased 
packing value induced by cholesterol increases the kinetic and energetic 
stability of α-helix H2. 
3.3.2.6 [H2.2-E1] 
Cholesterol slightly increased the ground-to-transition state 
distance by 0.08 nm and, thus, the conformational variability of [H2.2-
E1]. Furthermore, cholesterol increased the kinetic stability of this 
structural segment 13-fold, and increased the height of the free energy 
barrier by 2.6 !!! (≈15%). Cholesterol increases the packing value of α-
helix H2 and interacts with [H2.2-E1] through an interaction with V81 
(217). The changes in [H2.2-E1] might also be indirectly induced by 
electrostatic interactions between the cholesterol hydroxyl group and 
positively charged residues (e.g. K97) of extracellular loop E1. 
3.3.2.7  [H3-C2-H4-E2-H5.1] 
Although transmembrane α-helices H3 and H4 are supposed to 
establish direct interactions with cholesterol (217), the energy landscape 
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of the core segment remained unchanged by the presence of cholesterol. 
This finding was surprising because it was recently detected that [H3-C2-
H4-E2-H5.1] changes energy landscape in the presence of agonists and 
inverse agonists (245). However, the core segment [H3-C2-H4-E2-H5.1] 
exposed a relatively high conformational variability (high !!) and high 
mechanical elasticity (low !) compared to the other structural segments 
of β2AR in the presence of cholesterol. Thermal stability assays showed 
that cholesterol increased the packing value, and thus, the thermal 
stability of transmembrane α-helix H4 (217), which is part of the core 
segment. Furthermore, the crystal structures of cholesterol bound β2AR 
were determined from solubilized and liganded receptors (217). In 
contrast to these measurements, we characterized unliganded β2AR 
reconstituted into liposomes. It may be speculated that the different 
experimental conditions cause this apparent discrepancy. However, the 
short α-helical region of loop E2 contains two disulfide bonds that link 
transmembrane α-helices H3, H4 and H5 (65) and stabilize the core 
segment of β2AR. In addition, the structural core segment contains 
multiple ligand binding sites (188, 189). It has been also shown that 
cholesterol is required for efficient ligand binding of β2AR (246). Thus, the 
finding that the core segment of β2AR retains its relatively high 
conformational variability and mechanical flexibility in the presence of 
cholesterol may be of functional importance for ligand binding. 
3.3.2.8  [H5.2-C3-H6.1] 
Cholesterol significantly increased the kinetic stability of [H5.2-C3-
H6.1] 25-fold and increased the height of the energy barrier, ∆!!‡, by 3.2 !!! (≈17%). The distance between ground and transition state as well as 
the spring constant of [H5.2-C3-H6.1] remained unchanged. These 
changes are surprising, since cholesterol does not directly interact with 
structural segment [H5.2-C3-H6.1]. Thus, it can be assumed that 
cholesterol induced these changes by modulating the biophysical 
properties of the lipid membrane (14, 239, 240) or/and by indirect 
interactions in β2AR. As assessed by proteolysis and split receptor 
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studies, co-transfection of a plasmid encoding the N-terminus to α-helix 
H5 and a plasmid encoding α-helix H6 to the C-terminus generates a 
functional ‘split’ receptor (247). The interface between both fragments 
locates at segment [H5.2-C3-H6.1]. Furthermore, the N- and C-terminal 
regions of cytoplasmic loop C3 are involved in G protein activation and 
are crucial for the formation of interactions between GPCR and G protein 
(248). These GPCR and G protein interactions require cholesterol (249). 
Thus, it may be speculated that that the kinetic and energetic stability of 
[H5.2-C3-H6.1] increased by cholesterol may play a role in regulating the 
interactions between β2AR and G proteins. 
3.3.2.9 [H6.2-E3-H7-H8] 
In the presence of cholesterol, structural segment [H6.2-E3-H7-H8] 
significantly increased the kinetic stability !! 4-fold and increased the 
free energy barrier, ∆!!‡, by 1.5 !!! (≈8%). The oligomerization of class A 
GPCRs involves the interface between α-helices H1 and H8 (243, 244). 
Similar to segments [H1.1] and [H1.2-C1] it may be speculated that 
cholesterol affects oligomerization of β2AR by modulating the kinetic and 
the energetic stability of [H6.2-E3-H7-H8]. Furthermore, α-helix H8, 
which lies parallel to the membrane, might be affected by the composition 
of the membrane, for example through electrostatic interactions with 
polar lipid headgroups or the hydroxyl group of cholesterol (217). 
3.3.2.10 [CT] 
Cholesterol induced significant changes in [CT], which increased 
kinetic stability 10-fold and free energy by 2.5 !!!  (≈12%). The C-
terminal end of β2AR is not known to contribute to cholesterol binding to 
the receptor (217). Thus, it might be speculated that the changing 
properties of segment [CT] could be indirectly caused by cholesterol 
modulating the biophysical properties of the lipid bilayer. However, [CT] 
contains charged amino acid residues, which might establish electrostatic 
interactions with the interfacial region of the membrane, to which the 
cholesterol hydroxyl group contributes. [CT] is functionally important 
since it interacts with G protein-coupled receptor kinases, arrestin and 
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further signaling molecules (250). For instance, the C-terminal binding 
domain is required to direct the trafficking of β2AR to cholesterol-rich 
caveolae (251). Therefore, it can be assumed that the properties of [CT] 
changed by cholesterol in turn influence the way signaling molecules 
interact with β2AR. 
3.4 Ligand-specific changes of the β2AR 
3.4.1 Results 
3.4.1.1 Determining energetic, kinetic and mechanical properties 
of structural segments of β2AR in the presence of ligands 
To investigate to which extent the binding of different ligands 
affects the energy landscape of β2AR (reconstituted into DOPC/CHS 
proteoliposomes), DFS was carried out in the unbound state and in the 
presence of the synthetic agonists BI-167107 (BI, Boehringer-Ingelheim) 
and THRX-144877 (THRX, Theravance), the natural agonist adrenalin, 
the inverse agonist carazolol and the neutral antagonist alprenolol. For 
all pulling velocities superimpositions of the F-D curves did not change 
drastically upon ligand binding to β2AR. Next, the most probable 
unfolding force !∗ of every force peak characterizing a stable structural 
segment of β2AR was determined and plotted for the different loading 
rates !!∗ (Figure 3.11). 
3.4.1.2 Ligands change energy landscape of β2AR 
Fitting the DFS plots using Equation 2.8 (Figure 3.11) revealed 
the transition state !! , transition rate !! , free energy ∆!!‡ , and 
mechanical spring constant !  characterizing every structural segment 
(Figure 3.8). Differences between these parameters imply that the 
kinetic stability and mechanical nature of molecular interactions changed 
in the presence of ligands (Table 3.4). To determine the statistical 
significance of these differences, DFS plots from ligand-free and ligand-
bound β2AR were fitted simultaneously, resulting in a common estimate 
for !!  and !!. The sum of squares of both separate and simultaneous fits 
was assessed by an F-test (Table 3.5) (235, 236). Several segments 
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showed statistically significant differences after ligand binding (Table 
3.4). In the following the significant differences detected in the 
experiments will be described. 
 
Figure 3.11: DFS plots reveal loading rate dependent interactions stabilizing 
β2AR. For each stable structural segment of β2AR the most probable unfolding force was 
plotted against the loading rate. DFS fits using Equation 2.8 (see section 2.8.3) are 
shown for unliganded (red), alprenolol bound (black), carazolol bound (green), BI bound 
(blue), THRX bound (orange) and adrenalin bound (violet) states. Values for !! and !! 
obtained from fitting the DFS plots are given in Table 3.4. Error bars represent the 
standard error of most probable force and loading rate. 
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Table 3.5 (next page): Statistical analysis of DFS data. Sum of squares F-test for 
DFS data of unliganded β2AR compared to β2AR bound to BI, THRX, adrenalin, 
carazolol and alprenolol. Degrees of freedom (dof) are given in parentheses. SMFS data 
were fitted individually and simultaneously (unliganded and liganded). The difference in 
the fits that were analyzed separately or simultaneously was assessed by F-tests. The F-
ratio given by F=((SSQ1-SSQ2)/(dof1-dof2))/(SSQ2/dof2) quantifies the relationship 
between the relative increase in the sum of squares and the relative increase in the 
degrees of freedom. SSQ1 and SSQ2 refer to the sum of the two compared fits; dof1 and 
dof2 denote the degrees of freedom of the two compared fits. p-values estimate the 
significance to the unliganded state. 
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Structural segment Ligand Sum of squares (dof) F-ratio p-value 
Separate Common 
[H1] 
Unliganded 154.1 (5) - - - 
BI 277.8 (5) 441 (12) 0.105 0.955 
THRX 68.9 (5) 261.1 (12) 0.854 0.496 
Adrenalin 62.1 (5) 263.6 (12) 1.096 0.395 
Carazolol 131 (5) 378.1 (12) 1.631 0.244 
Alprenolol 86.7 (5) 522.5 (12) 5.849 0.014 
[H1.2-C1] 
Unliganded 214 (5) - - - 
BI 250 (5) 623.5 (12) 1.719 0.226 
THRX 196.8 (5) 423.6 (12) 0.156 0.924 
Adrenalin 90 (5) 312.9 (12) 0.146 0.930 
Carazolol 314.2 (5) 2426.5 (12) 17.970 2.36810-4 
Alprenolol 523.4 (5) 1064.5 (12) 2.218 0.149 
[H2.1] 
Unliganded 253.7 (5) - - - 
BI 524.9 (5) 1144.7 (12) 2.351 0.134 
THRX 57.5 (5) 411.2 (12) 1.607 0.249 
Adrenalin 119.5 (5) 394.1 (12) 0.280 0.839 
Carazolol 308.3 (5) 1232.5 (12) 5.965 0.013 
Alprenolol 624.3 (5) 1065.9 (12) 1.070 0.405 
[H2.2-E1] 
Unliganded 164.5 (5) - - - 
BI 289.4 (5) 503.4 (12) 0.938 0.458 
THRX 101 (5) 322.9 (12) 1.081 0.401 
Adrenalin 111.8 (5) 376 (12) 1.805 0.210 
Carazolol 249.1 (5) 609.1 (12) 2.363 0.133 
Alprenolol 267.6 (5) 497.1 (12) 0.752 0.546 
[H3-C2-H4-E2-H5.1] 
Unliganded 24 (5) - - - 
BI 116.6 (5) 2582.3 (12) 86.831 1.8410-7 
THRX 68.3 (5) 1443.7 (12) 73.207 4.16310-7 
Adrenalin 44.8 (5) 760.9 (12) 19.964 1.52310-4 
Carazolol 96.9 (5) 1128.6 (12) 41.675 5.84210-6 
Alprenolol 177.8 (5) 262.6 (12) 1.506 0.272 
[H5.2-C3-H6.1] 
Unliganded 497.7 (5) - - - 
BI 278.4 (5) 832.3 (12) 0.362 0.782 
THRX 86.3 (5) 588.6 (12) 0.039 0.989 
Adrenalin 148.2 (5) 339.7 (12) 0.890 0.479 
Carazolol 295.7 (5) 927.6 (12) 0.846 0.500 
Alprenolol 263.9 (5) 861.9 (12) 0.658 0.596 
[H6.2-E3-H7-H8] 
Unliganded 138.9 (5) - - - 
BI 58.9 (5) 260.4 (12) 1.582 0.255 
THRX 89.5 (5) 289.5 (12) 1.338 0.317 
Adrenalin 146.2 (5) 289.5 (12) 0.958 0.450 
Carazolol 87.6 (5) 451.9 (12) 4.976 0.023 
Alprenolol 266.4 (5) 499 (12) 1.156 0.374 
[CT] 
Unliganded 90.6 (5) - - - 
BI 84.3 (5) 200.3 (12) 0.726 0.559 
THRX 66.14 (5) 183.2 (12) 0.844 0.500 
Adrenalin 72.4 (5) 218.8 (12) 1.712 0.227 
Carazolol 97.82 (5) 288.9 (12) 2.665 0.105 
Alprenolol 165.7 (5) 262.6 (12) 0.123 0.944 
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3.4.1.3 Structural segments changing conformational variability 
upon ligand binding 
The distance between ground state and transition state !! 
approximates the conformational variability of a structure (Figure 2.3, 
see section 2.8.3) (237, 238). If a narrow energy valley stabilizing a 
structural segment becomes wider after binding of a ligand, the ligand 
increases the number of conformational states (i.e., conformational 
variability) the structural segment can adopt. Such an effect was 
observed upon ligand binding to β2AR (Table 3.4). Binding of agonists 
(BI, THRX, or adrenalin) significantly increased the conformational 
variability of the core segment [H3-C2-H4-E2-H5.1] (p < 0.001), carazolol 
significantly increased the conformational variability of structural 
segments [H1.2-C1] (p < 0.001), [H3-C2-H4-E2-H5.1] (p < 0.001), and 
[H6.2-E3-H7-H8] (p < 0.05), whereas alprenolol significantly increased 
the conformational variability of [H1.1] (p < 0.05) (Table 3.4). These 
results show that ligand binding increases the conformational variability 
(or states) of certain structural regions of β2AR whereas all other 
structural regions were not affected significantly. It appeared, that some 
structural regions were modulated by different ligands whereas other 
regions were modulated by only one ligand. However, to which extent the 
conformational variability of a structural region changed was specific to 
the ligand. 
3.4.1.4 Structural segments changing lifetime upon ligand 
binding 
The transition rate !!  measures the lifetime (reciprocal of 
transition rate) of a structural segment. The DFS experiments (Table 
3.4) detected that binding of BI, THRX, or adrenalin significantly 
increased the lifetime of the structural segment [H3-C2-H4-E2-H5.1] 
(p < 0.001), that carazolol binding significantly increased the lifetime of 
the structural segments [H1.2-C1] (p < 0.001), [H2.1] (p < 0.05), [H3-C2-
H4-E2-H5.1] (p < 0.001) and [H6.2-E3-H7-H8] (p < 0.05), and that 
alprenolol binding significantly increased the lifetime of the structural 
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segment [H1.1] (p < 0.05) (Table 3.4). These results demonstrate that 
ligand binding changes the kinetic properties of structural regions within 
β2AR. However, to which extent the kinetic properties of a structural 
region changed was again specific to the ligand. 
3.4.1.5 Structural segments changing free energy upon ligand 
binding 
The free energy ∆!!‡ characterizes the height of the energy barrier 
stabilizing a folded structure (Figure 2.3, see section 2.8.3). DFS 
measurements showed that ligand binding increased the free energy of 
several structural segments (Table 3.4). Binding of BI, THRX and 
adrenalin significantly increased ∆!!‡ of structural segment [H3-C2-H4-
E2-H5.1] (p < 0.001), carazolol significantly increased ∆!!‡ of structural 
segments [H1.2-C1] (p < 0.001), [H2.1] (p < 0.05), [H3-C2-H4-E2-H5.1] 
(p < 0.001) and [H6.2-E3-H7-H8] (p < 0.05), and alprenolol significantly 
increased ∆!!‡ of structural segment [H1.1] (p < 0.05). 
3.4.1.6 Structural segments changing mechanical properties upon 
ligand binding 
Similar to the other parameters characterizing the energy barriers 
the spring constants ! that quantify the mechanical rigidity of structural 
segments (135, 230), changed upon ligand binding (Table 3.4). Binding of 
the agonists BI, THRX, and adrenalin significantly increased the 
mechanical elasticity of the core structural segment [H3-C2-H4-E2-H5.1] 
(p < 0.001), and alprenolol significantly decreased the mechanical 
elasticity of structural segment [H1.1] (p < 0.05). Carazolol significantly 
increased the mechanical elasticity of structural segments [H1.2-C1] 
(p < 0.001), [H3-C2-H4-E2-H5.1] (p < 0.001), and [H6.2-E3-H7-H8] 
(p < 0.05), and decreased that of structural segment [H2.1] (p < 0.05). 
These results showed that the binding of a ligand changed the 
mechanical properties of certain structural regions. 
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3.4.2 Discussion 
3.4.2.1 Ligand binding to β2AR lacks pronounced localized 
interactions 
As for all membrane proteins investigated so far by SMFS (114, 
129, 130, 133, 135, 156, 233, 234) the F-D spectra recorded during 
mechanical unfolding of native-like β2AR reconstituted into 
proteoliposomes showed a reproducible pattern of force peaks (Figure 
3.4C and Figure 3.6). The reproducibility of the force peak pattern 
suggests that β2AR establishes a characteristic interaction network (125). 
Ligand binding to the receptor did not establish additional force peaks or 
significantly modify the strength of existing force peaks. In contrast, 
SMFS detected a significantly increased force peak after ligand binding to 
functionally activated Na+/H+ antiporters NhaA from Escherichia coli and 
MjHhaP1 from Methanococcus jannaschii (127, 128). The increasing 
interaction force was correlated to specific interactions established 
between the ligand Na+ and the deprotonated aspartic acid residues at 
the Na+-binding site. In β2AR multiple amino acid residues from several 
transmembrane α-helices contribute to ligand binding (188, 189). Thus, it 
is expected that ligand binding modulates the functional state of β2AR by 
changing the interaction network in the GPCR (224, 252). However, 
because no drastic changes of the force peak pattern were detected such 
as observed for other membrane proteins after ligand binding (127, 128), 
it can be concluded that ligand binding established rather small changes 
to the interactions that structurally stabilize β2AR in the unliganded 
conformation. 
3.4.2.2 Conformational variability and kinetic stability of 
unliganded β2AR 
DFS studies showed that structural segments of bacteriorhodopsin, 
bovine and mouse rhodopsin, the antiporter NhaA and the transporter 
BetP are stabilized by single energy barriers (Figure 2.3, see section 
2.8.3) (129, 133, 232, 234, 253). The same observation was made for the 
structural segments of β2AR. The transition state distance !! separating 
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the folded from the unfolded state of every structural segment of β2AR 
ranged from 0.3 to 0.6 nm (Table 3.4). Thus the structural segments of 
β2AR must be stretched by ≈0.3 to 0.6 nm to induce unfolding. These 
rather short distances suggest that short ranged inter- and 
intramolecular bonds, such as hydrogen bonds, van-der-Waals 
interactions, or electrostacit interactions had to be ruptured to induce 
unfolding of the receptor. On average, the transition state distance of 
structural segments determined of β2AR was similar to the average 
values of ≈0.4 nm determined for structural segments stabilizing 
bacteriorhodopsin, bovine rhodopsin and NhaA (!! ranging from 0.2 to 0.8 
nm) (129, 232, 234, 253). The structural segments of unliganded β2AR 
revealed transition rates !!  between 0.011 and 0.320 s-1 (Table 3.4), 
indicating lifetimes ranging between ≈3 and ≈90 s. These transition rates 
were in the range of those measured for other membrane proteins 
ranging from 0.001 to 0.9 s-1 (129, 232, 234, 253). However, the !! values 
of the structural segments of β2AR differed by a factor of 30 with 
structural segments [H1.1], [H3-C2-H4-E2-H5.1] and [CT] representing 
the kinetically stable regions, and [H1.2-C1], [H2.1] and [H6.2-E3-H7-H8] 
the kinetically less stable ones. Biophysical and functional studies 
support a multistate model of β2AR in the absence of ligands (254). These 
multiple conformational and functional states observed for unliganded 
β2AR may be directly related to the conformational variability and kinetic 
heterogeneity of the receptor’s structural segments observed by DFS. 
3.4.2.3 Energetic stability and mechanical elasticity of 
unliganded β2AR 
The free energy barrier ∆!!‡ stabilizing the structural segments of 
unliganded β2AR ranged from ≈20 to 23 !!! . These free energy 
differences were below that determined for structural segments of bovine 
rhodopsin in the inactive dark-state (∆!!‡ between 20 and 28 !!!) and 
below those determined for the structurally similar but functionally 
different bacteriorhodopsin (∆!!‡ between 21 and 29 !!!) (234, 253). Thus 
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the structural segments of unliganded β2AR were energetically less stable 
compared to those of bovine rhodopsin and bacteriorhodopsin. 
Spring constants characterizing the mechanical elasticity of 
structural segments in the unliganded state varied by a factor of four 
(Table 3.4). The intracellular end of α-helix H1 together with the first 
intracellular loop [H1.2-C1] (!=2.02 N/m) and the structural segment 
[H5.2-H6.1-C3] (!=2.23 N/m) formed the most rigid structures of the 
receptor. In contrast, the core segment [H3-C2-H4-E2-H5.1] (!=0.59 N/m) 
and the C-terminal domain [CT] (!=0.54 N/m) formed the most elastic 
segments. In general, the structural segments stabilizing β2AR were more 
elastic compared to the structural segments of bacteriorhodopsin, where 
the values for ! ranged from 0.9 to 4.2 N/m (253). Compared to the 
elasticity of the structural segments of bovine rhodopsin (! between 0.16 
and 2.54 N/m) (234), the values observed for β2AR were more similar, 
indicating that both class A GPCRs share consistent mechanical 
properties. However, the spring constants of the structural core segments 
[H3-C2-H4-E2-H5.1] of both GPCRs differed from each other. In the case 
of unliganded β2AR, !  was about four times lower than !  of bovine 
rhodopsin in the dark-state. 
3.4.2.4 High conformational variability and mechanical elasticity 
of structural core correlates to basal β2AR activity 
Parameters characterizing the energy barrier stabilizing 
unliganded β2AR describe the receptor in its basal and low energy state 
(224). It has been suggested that the basal activity of β2AR in the absence 
of ligands may be attributed to an inherent structural flexibility and 
tendency to adopt several conformational states (224). In the 
measurements, the largest segment in the receptor core [H3-C2-H4-E2-
H5.1] exposed a relatively high conformational variability (high !!) and 
high mechanical elasticity (low ! ) compared to the other structural 
segments of β2AR and compared to the core segment of the GPCR bovine 
rhodopsin in the dark-state. This dark-state of rhodopsin is stabilized by 
the covalently bound chromophore that acts as inverse agonist and traps 
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the GPCRs in the inactive state (255, 256). Since the core segment of 
β2AR contains multiple ligand-binding sites (188, 189), the increased 
conformational variability and mechanical elasticity allows the core to 
sample more conformational states required to interact with a variety of 
different ligands. Thus, the DFS experiments suggest that the high 
conformational variability and mechanical elasticity of the core segment 
(Table 3.4) contribute to the basal activity of β2AR and favor ligand 
binding. 
3.4.2.5 Properties of β2AR modified by the neutral antagonist 
alprenolol 
Neutral antagonists bind in the orthosteric pocket of a GPCR but 
have little or no effect on basal activity. In contrast to all other ligands 
tested, the neutral antagonist alprenolol only modulated the N-terminal 
region of transmembrane α-helix H1 ([H1.1]) and widened the energy 
valley !!  from 0.44 nm (unliganded) to 0.75 nm. Thus, alprenolol 
enhanced the conformational variability of the extracellular half of α-
helix H1. Furthermore, binding of alprenolol significantly reduced the 
transition rate !! and increased the lifetime of structural segment [H1.1]. 
The free energy ∆!!‡ stabilizing structural segment [H1.1] increased by ≈7 !!!, whereas the spring constant ! decreased to 0.40 N/m (0.88 N/m in 
the unliganded state). These changes show that alprenolol kinetically and 
energetically stabilizes the extracellular part of α-helix H1 and enhances 
its mechanical elasticity. Available crystal structures do not explain these 
observations. It has been suggested that α-helix H1 is involved in 
receptor silencing by oligomerization (243, 244). Therefore, it may be 
speculated that the alprenolol induced kinetic and energetic stabilization 
as well as the structural softening of the extracellular half of α-helix H1 
favor oligomerization of the receptor. 
Although the affinity of alprenolol (Kd≈1 nM) is comparable to that 
of the agonist THRX and greater than that of adrenalin, binding of the 
neutral antagonist did not show any effects on the structural core 
segment [H3-C2-H4-E2-H5.1]. Thus, alprenolol established very different 
Molecular interactions of the human β2AR 
 70 
interactions compared to THRX and to other agonists (Table 3.4). A 
possible explanation for this quite unique interaction pattern established 
in β2AR could be that alprenolol has a single aromatic ring that cannot 
establish strong interactions with F193 of loop E2, as shown by molecular 
dynamics docking simulations (257). Moreover, in contrast to both 
agonists and carazolol, alprenolol does not form polar interactions with 
serine residues of α-helix H5. This may explain that alprenolol cannot 
establish interactions at the core segment that are supposed to change 
the activity of β2AR. In summary, the DFS measurements unravel how a 
neutral antagonists works by simply constricting the access of other 
ligands to the receptor (258) and avoiding interactions at functionally 
important regions. 
3.4.2.6 An overall scheme: most ligands modulate the structural 
core segment of β2AR 
To investigate to which extent ligands change the energetic, kinetic 
and mechanical properties of β2AR, DFS was applied in the presence of 
the synthetic agonists BI and THRX, the natural agonist adrenalin, the 
inverse agonist carazolol or the neutral antagonist alprenolol. Figure 
3.12 highlights which ligands modulate the properties of different 
structural segments of β2AR. Binding of both agonists and the inverse 
agonist carazolol significantly modified the energetic, kinetic and 
mechanical parameters of the structural core segment [H3-C2-H4-E2-
H5.1]. The magnitude of the effect correlates relatively well with ligand 
affinity, with the lowest values being observed for the highest affinity 
ligands. This is may be explained by extensive interactions between 
ligands and transmembrane α-helices H3 and H5. As noted above, the 
small effect observed for the neutral antagonist alprenolol may be 
explained by the absence of polar interactions between alprenolol and 
transmembrane α-helix H5. In the presence of agonists and carazolol, the 
energy valley stabilizing the structural core segment increased its 
distance to the transition state !! from 0.55 nm (unliganded β2AR) to 0.73 
nm (THRX), 0.71 nm (BI), 0.65 nm (adrenalin) and 0.79 nm (carazolol). 
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This shift towards wider energy valleys in these ligand bound states 
implies that the core segment [H3-C2-H4-E2-H5.1] increases 
conformational variability in response to ligand binding. Furthermore, 
the reduction of the transition rate !! of the core segment by several 
orders of magnitude suggests that this structural region of β2AR 
increases lifetime by orders of magnitude in the presence of BI, THRX, 
adrenalin or carazolol. The spring constant ! of the core segment [H3-C2-
H4-E2-H5.1] is slightly reduced from 0.59 N/m (unliganded state) to 0.48 
N/m (BI), 0.44 N/m (THRX), 0.49 N/m (adrenalin) and 0.39 N/m 
(carazolol). This reduction in ! indicates that the core segment increases 
mechanical elasticity by ≈10-20%. Finally, ligand binding stabilized the 
β2AR core segment [H3-C2-H4-E2-H5.1] by increasing free energy ∆!!‡ by 
7.7 !!! (BI), 6.9 !!! (THRX), 3.2 !!! (adrenalin) and 7.6 !!! (carazolol), 
compared to unliganded β2AR. Thus, the high-affinity ligands BI, THRX 
and carazolol increased the free energy stabilizing the core segment twice 
as much compared to the natural agonist adrenalin. 
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Figure 3.12: Structural segments 
of β2AR changing properties 
upon ligand binding. Structural 
segments that significantly change 
their energetic, kinetic and 
mechanical properties upon binding 
of BI, THRX or adrenalin (A), 
carazolol (B) and alprenolol (C) are 
highlighted (β2AR structure PDB ID 
code 2RH1). Arrows denote 
increasing (arrow up) and decreasing 
(arrow down) parameters 
characterizing the width of the 
energy valley (!! ), transition rate 
(!!), energy barrier (∆!!‡), and spring 
constant ( ! ) of stable structural 
segments. Trends were taken from 
Table 3.4. 
Structural and functional data suggest that the core segment [H3-
C2-H4-E2-H5.1] is important for ligand binding and β2AR activation: (i) 
several amino acid residues of transmembrane α-helices H3 and H5 are 
part of the ligand-binding pocket (259). For instance, H3 and H5.1 
establish polar interactions and hydrophobic contacts with BI (189). Two 
residues of H3, D113 and V114, contribute to agonist binding (189). 
Furthermore, S203 of H5.1 is crucial for agonist binding, as shown by 
mutagenesis studies (260, 261). (ii) Receptor activation by agonists 
involves disruption of the ionic lock, which links the cytoplasmic parts of 
α-helices H3 and H6 in the inactive state (262, 263). (iii) The second 
intracellular loop C2 is important for the efficiency of G protein activation 
and contains a switch that enables G protein coupling (264, 265). 
In summary, DFS detected that binding of agonists and the inverse 
agonist carazolol increases structural flexibility, energetic stability and 
lifetime (kinetic stability) of the functionally important core segment [H3-
C2-H4-E2-H5.1]. These altered properties of the core segment enable 
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β2AR to adopt certain conformations, which are supposed to represent an 
active state. 
The affinities of the agonists investigated range from Kd=0.84 pM 
(BI) to Kd=3.68 µM (adrenalin). Kd of THRX is ≈1 nM. Each agonist 
changed the conformational variability, kinetic stability, energetic 
stability, and mechanical elasticity of the structural core segment [H3-
C2-H4-E2-H5.1] differently. A systematic change may be found between 
the kinetic stability of [H3-C2-H4-E2-H5.1], which increased with 
increasing affinity of the agonists that bound to β2AR. However, it should 
be noted that binding of agonists alone is insufficient to stabilize β2AR in 
the active state (266, 267). Even binding of full agonists cannot stabilize 
every β2AR in the active state (219, 268). The reason for this apparent 
discrepancy is that although bound to a ligand the probability of β2ARs to 
adopt other functional states lowers but does not approach zero (224). 
Interestingly, the active state can be further stabilized through 
interactions with G proteins or camelid antibodies (nanobodies) that 
exhibit G protein-like behavior (189, 267). Characterizing such stable 
β2AR/G protein complexes using DFS may be useful to quantify the 
conformational variability, kinetic stability, energetic stability, and 
mechanical elasticity of the structural core segment [H3-C2-H4-E2-H5.1] 
in the fully active state. 
3.4.2.7 The inverse agonist carazolol introduces major 
modifications to β2AR 
Among all ligands tested, carazolol modulated the properties of 
most structural segments of β2AR. Besides changing the energetic, kinetic 
and mechanical properties of the core segment [H3-C2-H4-E2-H5.1] such 
as observed for the agonists, carazolol significantly affected three other 
structural segments [H1.2-C1], [H2.1], and [H6.2-E3-H7-H8] (Table 3.4). 
Carazolol widened the energy valley stabilizing [H1.2-C1], [H3-C2-H4-E2-
H5.1], and [H6.2-E3-H7-H8] by 0.10-0.27 nm. This indicates that these 
segments enhanced their conformational variability. Furthermore, 
carazolol reduced the transition rate !! and, thus, increased the lifetime 
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of each of the four structural segments by up to 6 orders of magnitude. 
The free energy ∆!!‡ of structural segments [H1.2-C1] and [H3-C2-H4-E2-
H5.1] increased by ≈10 !!! . Carazolol slightly lowered the spring 
constants !   of structural segments [H2.1], [H3-C2-H4-E2-H5.1] and 
[H6.2-E3-H7-H8], thereby increasing their structural elasticity. The 
strongest effect was observed for the structural segment [H1.2-C1], where ! reduced from 2.02 N/m in the unliganded state to 0.83 N/m in the 
carazolol-bound state. 
Several amino acid residues of α-helices H3, H5, H6 and H7 are 
important for carazolol binding (188). For instance, W109, V114 and V117 
of α-helix H3 establish hydrophobic contacts with carazolol. Additionally, 
polar interactions between carazolol and D113 of α-helix H3 as well as 
S203 of H5.1 are crucial for carazolol binding. Furthermore, hydrophobic 
contacts between W286, F289 and F290 of α-helix H6 and carazolol 
contribute to binding of the inverse agonist (65, 66). Moreover, loop E2 of 
the structural segment [H3-C2-H4-E2-H5.1] establishes a salt bridge 
with extracellular loop E3 in the inactive state (257). Carazolol stabilizes 
packing interactions involving I121 (H3), P211 (H5.1), F282 (H6.2) and 
N318 (H7) that contribute to a network of interactions that stabilize an 
inactive conformation of the receptor (267). Thus, from this point it may 
not be surprising that the experiments detect that the structural 
segments [H3-C2-H4-E2-H5.1] and [H6.2-E3-H7-H8] change their 
properties upon carazolol-binding. However, DFS quantifies to which 
extent the properties of these and other structural regions change. 
3.4.2.8 Carazolol modifies structural regions proposed to be 
involved in oligomerization 
Inverse agonists promote higher-order β2AR oligomerization that 
alters access to other signaling proteins (225). The significant changes of 
the energy barriers ( !! , !!  and ∆!!‡ ) and spring constants ( ! ) 
characterizing the structural segments [H1.2-C1], [H3-C2-H4-E2-H5.1] 
and [H6.2-E3-H7-H8] in the presence of carazolol are of particular 
interest because they significantly increase conformational variability, 
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mechanical flexibility, kinetic stability and energetic stability upon 
carazolol-binding. It has been proposed for several other class A GPCRs 
that oligomerization involves primarily the interface between α-helices 
H1 and H8 (243, 244). Thus, all structural segments changing their 
properties may contribute to the oligomerization of β2AR. Particularly α-
helices H4 and H5 are involved in the native packing arrangement of 
rhodopsin and define the rhodopsin dimer (243). It is therefore likely that 
the increased conformational variability of the core segment [H3-C2-H4-
E2-H5.1] contributes to the formation of dimers and higher-ordered 
oligomers in the presence of carazolol. Conversely, interactions between 
protomers that change their oligomeric state can influence the 
parameters quantified by DFS (136). Thus, it cannot be distinguished 
whether changes of the structural segments are induced by carazolol 
binding or carazolol-induced oligomerization. 
3.4.2.9 Carazolol employs direct and indirect interactions to 
modify structural regions 
Although carazolol binds to β2AR with picomolar affinity 
(comparable to BI), it significantly changed the energy landscape of four 
structural segments. The effect of carazolol on the energy landscape of 
the receptor is more pronounced compared to the effects caused by any of 
the other agonists or the neutral antagonist investigated. Not all of the 
structural segments are supposed to interact directly with carazolol (188). 
Thus, it can be concluded that carazolol binding changes the properties of 
the structural regions of β2AR by direct interactions and by indirect 
interactions, which do not result from directly contacting the ligand. 
3.5 Conclusions 
Energy landscapes describe conformational variability, kinetic 
stability, energetic stability and mechanical elasticity of proteins (231). 
GPCRs adopt many different conformations that are closely related to 
functional states (224). The work presented here contributes to a more 
detailed understanding of the energetic, kinetic and mechanical 
properties of native-like β2AR reconstituted into membranes of 
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phospholipids and cholesterol. It was observed that the interactions of 
unliganded β2AR stabilize well-defined structural segments of the 
receptor. 
Cholesterol considerably increased the strength of interactions 
stabilizing structural segments of β2AR. These interactions introduced by 
cholesterol were sufficient to increase the kinetic, energetic, and 
mechanical stability of all structural segments stabilizing β2AR except for 
the structural core segment [H3-C2-H4-E2-H5.1], whose properties were 
not significantly influenced by cholesterol. Because the core segment of 
β2AR is involved in ligand binding, this finding indicates that cholesterol 
may not necessarily influence the binding of a ligand to the structural 
core segment. It could not be distinguished to which extent the change 
introduced to all other stable structural segments were caused by the 
binding of cholesterol to the receptor or indirectly through the ability of 
cholesterol to modulate the properties of the lipid bilayer. At least the 
structural segments of β2AR that do not expose cholesterol binding sites 
must have changed properties through indirect interactions mediated by 
cholesterol. In summary the changing properties detected in the presence 
of cholesterol are of sufficient magnitude to alter the structure and 
function relationship of β2AR (245). The fact that cholesterol increases 
stability of the receptor supports the hypothesis that cholesterol is an 
essential component in the crystallization of β2AR (65). Taken together, 
the unchanged structural core segment containing multiple ligand 
binding sites and the changed properties of all other structural segments 
may represent a mechanism of how cholesterol modulates β2AR. As 
cholesterol may not necessarily influence the binding of a ligand to β2AR, 
the data suggests that in the presence of cholesterol the GPCR will react 
differently once a ligand has bound. 
In the presence of a ligand, SMFS could not detect drastic changes 
of interactions and the stabilizing structural segments did not change 
positions. Thus, it can be concluded that ligand binding to β2AR induces 
rather weak interactions instead of strong localized interactions. 
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However, DFS showed that the interactions established upon ligand 
binding were sufficient to change the conformational, energetic, kinetic 
and mechanical properties of structural segments of β2AR. Agonist or 
inverse agonist binding increased the conformational variability, kinetic 
stability, energetic stability and mechanical elasticity of the functionally 
important structural core segment [H3-C2-H4-E2-H5.1] of β2AR. To 
which extent individual ligands could change the properties of the core 
segment was intrinsic to the ligand. In contrast to the agonists (BI, 
THRX, and adrenalin), the inverse agonist carazolol affected, in addition 
to the core segment, three structural segments: [H1.2-C1], [H2.1], and 
[H6.2-E3-H7-H8]. Finally, the neutral antagonist alprenolol changed only 
the properties of structural segment [H1.1]. The functionally important 
structural core segment of the receptor remained unaffected by 
alprenolol. Taken together, theses single-molecule experiments reveal 
that ligands establish interactions that modulate the properties of 
distinct structural segments within β2AR. Quantifying the energetic, 
kinetic and mechanical parameters of the structural segments provides 
insight into how these structural segments stabilize ligand-specific 
conformations of the receptor. Depending on which structural segments 
change their energetic, kinetic or mechanical properties, the receptor 
samples more active states in the presence of agonists or more inactive 
states in the presence of the inverse agonist. 
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4 Single-molecule force spectroscopy from lipid 
nanodiscs 
Reprinted (adapted) with permission from Zocher M., C. Roos, S. 
Wegmann, P. D. Bosshart, V. Dotsch, F. Bernhard, and D. J. Muller. 
2012. Single-molecule force spectroscopy from nanodiscs: an assay to 
quantify folding, stability, and interactions of native membrane proteins. 
ACS Nano 6:961-971. Copyright 2012 American Chemical Society. 
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4.1 Introduction 
To reveal insights into membrane proteins by SMFS requires the 
membrane protein to be embedded in a lipid membrane. These 
membranes can be extracted from the native cell or synthetic lipid 
membranes into which the membrane protein has been reconstituted. In 
contrast to the thousands of different membrane proteins known, only a 
few could be reconstituted into the functionally important lipid 
membrane (13, 57, 269). These difficulties are based on the amphiphilic 
character of membrane proteins that once isolated from the cell 
membrane must be reconstituted into a lipid bilayer that mimics the 
native cellular membrane. 
Recently, phospholipid nanodiscs have been introduced to 
reconstitute membrane proteins into a native-like lipid environment (269-
271). Nanodiscs are composed of small patches (≈10-20 nm in diameter) of 
lipid bilayer framed by an amphiphilic membrane scaffold protein (MSP) 
to shield the hydrophobic fatty acid chains of the lipids from the aqueous 
buffer solution. MSP itself is based upon the sequence of human serum 
apolipoprotein A1, which are the primary component of high-density 
lipoproteins (rHDL). The shielding of hydrophobic interactions by the 
MSP makes lipid nanodiscs water-soluble. The phospholipids associate as 
a bilayer domain wile two MSP molecules wrap around the edges of the 
discoidal structure (272). One MSP covers the hydrophobic alkyl chain of 
each leaflet. Therefore, after integration into nanodiscs, membrane 
proteins can be handled similar to water-soluble proteins. Because the 
length of the scaffold protein determines the diameter of the nanodisc and 
the lipid composition of the nanodisc can be adjusted, the properties of 
the nanodisc can be tailored to favor the insertion of a particular 
membrane protein (271). Accordingly, several membrane proteins have 
already been embedded into lipid nanodiscs including the bacterial 
chemoreceptor Tar (273), cytochrome P450 (274), the translocon SecYEG 
(275), BR (276), β2AR (266, 277) and bovine rhodopsin (278). Structural 
and functional characterization of these membrane proteins 
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demonstrated that nanodiscs a capable of mimicking a physiological 
environment for in vitro studies (273, 279-282). 
Another bottleneck limits the applicability of SMFS to membrane 
proteins. To conduct SMFS the protein containing membrane must be 
first imaged and located so that the AFM tip can be attached to the 
membrane protein. Once the AFM tip has been attached the stability, 
folding and interactions of the membrane protein can be characterized 
(125, 156, 283). These constraints could be avoided if membrane proteins 
could be reconstituted into nanoscopic lipid bilayers that provide a native-
like environment of membrane proteins and that could be densely 
adsorbed onto the SMFS support. In a raster-like manner the AFM tip 
could then pick up and characterize one membrane protein after the other 
without the need of imaging. Dense adsorption layers on supporting 
surfaces can be prepared with hydrophilic water-soluble proteins (143). In 
contrast, reconstituted proteoliposomes showing a heterogeneous 
distribution of diameters from ≈50 to >500 nm. If adsorbed at higher 
concentration onto a support, proteoliposomes start forming aggregates 
that are not suitable for SMFS. However, in principle dense adsorption 
layers may be obtained using membrane proteins that are embedded in 
hydrophilic nanodiscs. Such improved preparation procedures would 
simplify SMFS of membrane proteins and be a basis to apply high-
throughput SMFS assays (284, 285) to study membrane protein (un-
)folding, stability and interactions. 
For these reasons, it was investigated whether membrane proteins 
reconstituted into phospholipid nanodiscs can be characterized by SMFS 
and to which extent the reconstitution into nanodiscs modulates the 
interactions guiding the stability and (un-)folding of membrane proteins. 
Among membrane proteins the light-driven proton pump 
bacteriorhodopsin (BR) from Halobacterium salinarum most probably 
represents the functionally and structurally best characterized example 
(286-289). Moreover, since many years BR serves as model to characterize 
the unfolding and folding of α-helical transmembrane proteins (44, 80, 
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156, 290, 291) (see section 2.8.1). Thus, BR was chosen as example for the 
SMFS studies presented here. For that purpose, BR from native purple 
membrane (BRPM) and BR reconstituted into phospholipid nanodiscs 
(BRND) were characterized by SMFS. The mechanical unfolding pathways 
and the stability of both BR samples were compared and their 
interactions mapped onto the BR structure. The results showed whether 
the reconstitution of BR into lipid nanodiscs alters the properties of BR 
and whether nanodiscs can in principle be applied to characterize 
membrane proteins by SMFS. 
4.2 Experimental procedures 
4.2.1 Expression and purification of MSP1 
MSP1 was expressed and purified in Volker Dötsch’s laboratory at 
the University of Frankfurt. Escherichia coli BL21 star (DE3, Invitrogen, 
Germany) were transformed with the plasmid containing the MSP1 gene 
(pET28b-MSP1). The MSP1 had an N-terminal 6-His affinity tag and a 
tobacco etch virus (TEV) protease cleavage site (271). A pre-culture was 
incubated overnight in lysogeny broth medium (supplemented with 30 µg 
kanamycin) and diluted 30-fold in expression media (lysogeny broth 
medium, supplemented with 0.5% (w/v) glucose and 30 µg/ml kanamycin). 
Escherichia coli were grown at 37°C with shaking (180 rpm). Expression 
of MSP1 was induced by adding isopropyl-b-D-thiogalactopyranosid 
(IPTG) to a final concentration of 1 mM when the optical density at λ = 
600 nm (OD600) reached 1. Subsequently, the cells were incubated under 
continuous shaking (180 rpm) for 1 h at 37°C before the temperature was 
decreased to 28°C for additional 4 h. Bacteria were pelleted and stored at 
-20°C. Bacteria pellets of 1.2 l expression culture were resuspended in 50 
ml breaking buffer (300 mM NaCl, 1 protease inhibitor tablet (cOmplete 
Protease Inhibitor Cocktail Tablet, Roche, Germany), 1 mM 
phenylmethanesulfonylfuoride (PMSF), 40 mM Tris-HCl, pH 8.0). Triton 
X-100 was added to a final concentration of 1% (v/v). Cells were disrupted 
using a Labsonic homogenizer (Braun, Germany) for 3 x 60 s and 3 x 45 s 
(pulse length 0.7 s) on ice. The suspension was centrifuged at 30.000g for 
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20 min to separate unbroken bacteria from bacteria debris. The 
supernatant was filtered (pore size 0.45 µm) before loading on an 
immobilized metal ion affinity chromatography column (IMAC Sepharose 
6 FF, GE Healthcare, USA). The IMAC column was equilibrated with 5 
column volumes of buffer 1 (300 mM NaCl, 40 mM Tris-HCl, 1% Triton-X 
(v/v), pH 8.0) before loading the supernatant. The column was washed 
successively with 5 column volumes of buffer 1 to 4 (buffer 2: 300 mM 
NaCl, 50 mM cholic acid, 40 mM Tris-HCl, pH 8.9; buffer 3: 300 mM 
NaCl, 40 mM Tris-HCl, pH 8.0; buffer 4: 300 mM NaCl, 50 mM imidazol, 
40 mM Tris-HCl, pH 8.0) followed by the elution of MSP1 with elution 
buffer (300 mM NaCl, 300 mM imidazol, 40 mM Tris-HCl, pH 8.0). Purity 
of the elution fraction was analysed by SDS-PAGE. MSP1-containing 
fractions were pooled and glycerol was added to a final concentration of 
10% (v/v) to prevent aggregation. MSP1 was dialysed against dialysis 
buffer (300 mM NaCl, 40 mM Tris-HCl, 10% glycerol (v/v), pH 8.0) for 16 
h at 4°C with one buffer exchange. The dialysis was performed using 
Spectra/Por dialysis membranes with 10 kDa molecular weight cut off 
(Spectrum Laboratories, USA). MSP1 concentration was determined by 
absorption spectroscopy using the molar extinction coefficient at λ = 280 
nm (ε = 24750 M-1cm-1). MSP1 was flash frozen in liquid nitrogen and 
stored at -80°C. 
4.2.2 Preparation of BR 
Purple membrane was kindly provided by G. Büldt. Purple 
membrane from strain H. salinarum S9 was purified as described (292). 
For reconstitution of BR into nanodiscs, purple membrane (concentration 
4.5-6 mg/ml) was mixed with an equal volume of solubilization buffer (40 
mM Na2HPO4/KH2PO4, 7.5% (w/v) n-octyl-β-D-glucopyranoside (β-OG, 
Sigma-Aldrich, Germany), pH 6.9) and incubated at 4°C for ≥2 days to 
extract BR from purple membrane. The solution was centrifuged at 
90.000g for 1 h to remove insoluble fragments. The supernatant 
containing solubilized BR (including some tightly bond purple membrane 
lipids) was used for nanodisc reconstitution with the BR concentration 
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being determined using the molar absorption coefficient at λ = 560 nm (ε 
= 42000 M-1cm-1). 
4.2.3 Reconstitution of BR into nanodiscs 
BR was reconstituted into nanodiscs in Volker Dötsch’s laboratory 
at the University of Frankfurt. Dimyristoylphosphatidylcholine (DMPC, 
Avanti Polar Lipids, USA) was added to water at a concentration of 50 
mM and solubilized by adding sodium cholate to a final concentration of 
100 mM. The detergent-lipid mixture was sonicated for 10 min at 35 kHz 
and 640 W in a water bath (Sonorex Super RK 510, Bandelin, Germany) 
and filtered (pore size 0.45 µm). BR was reconstituted into nanodiscs by 
mixing detergent-solubilized BR with MSP1 and DMPC at a 
stoichiometry of 1:1:10 (molar ratio). The BR-MSP1-DMPC mixture was 
incubated for 1 h at room temperature (≈23°C). To remove detergent and 
to induce nanodisc formation the mixture was dialyzed over night at room 
temperature against detergent-free buffer (100 mM NaCl, 40 mM Tris, 
pH 7.4) at a ratio ≥1:500. Since no purification step was performed after 
solubilization of BR, the nanodiscs also contained wild-type lipids from 
purple membrane. The following dialysis was performed at 4°C for 
additional 2 days. The detergent-free buffer was exchanged at least twice. 
To avoid photo bleaching of BR (293), all reconstitution procedures were 
carried out in the dark. After dialysis the aggregated material was 
removed by centrifugation at 22.000g for 20 min. The supernatant was 
concentrated using Amicon ultra centrifugal filter units (Millipore, 
Germany, 10 kDa molecular weight cut off) to a final volume of 0.5 ml. 
BRND complexes were purified using size-exclusion chromatography 
(Superdex 200, Tricorn 10/300, GE Healthcare, Germany) using dialysis 
buffer. Elution fractions with absorption maxima at λ = 530 nm were 
pooled and concentrated using ultra centrifugal filter units (Amicon, 10 
kDa molecular weight cut off) to a final concentration of ≈100 mM. 
Finally, the sample was centrifuged (20 min at 22.000g). The supernatant 
was stored at 4°C until analysis. 
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4.2.4 UV/vis spectra 
UV/vis spectra of BRND and BRPM were measured with a V-550 
spectrophotometer (Jasco, UK) at room temperature. BRPM was diluted 
with buffer solution (100 mM NaCl, 40 mM Tris-HCl, pH 7.4). The buffer 
was used for baseline setting. 
4.2.5 Circular dichroism 
Circular dichroism (CD) spectra are frequently used to measure 
assembly and disassembly of the BR lattice (294, 295). Thus, CD was 
applied to determine the assembly of BR in nanodiscs CD spectra were 
measured with a J-180 spectrometer (Jasco, UK) in buffer solution (100 
mM NaCl, 40 mM Tris-HCl, pH 7.4) at a protein concentration of 25.9 
µM. Measurements were carried out in a 1 mm cuvette at standard 
sensitivity with a band width of 3 nm, a response of 1 s and a scanning 
speed of 1 nm/s at 20°C. 
4.2.6 SMFS 
AFM imaging of BRPM and BRND was performed using a 
Nanowizard II (JPK Instruments, Germany) and a Multimode8 AFM 
(Bruker, Germany). SMFS on BRPM was conducted using a NanoWizard 
II (JPK Instruments), whereas BRND was approached using a ForceRobot 
300 (JPK Instruments). The rectangular 200 µm long AFM cantilevers 
(OMCL-RC800PSA, Olympus, Japan) having a nominal spring constant 
of ≈0.05 N/m were calibrated in buffer solution using the equipartition 
theorem (227). Determined spring constants were within ≈10% of each 
other. Experiments were carried out using AFM cantilevers from the 
same wafer. To non-specifically attach the AFM tip to BR, the tip was 
pushed on the purple membrane or BRND applying a force of ≈1 nN for 1 s 
(136, 156). Subsequent retraction of the AFM cantilever induced 
mechanical load that unfolded BR. While retracting the AFM cantilever 
at a velocity of 528 nm/s, the cantilever deflection was recorded to 
measure the force in dependence of the pulling distance. To record F-D 
curves, a x,y-raster of several hundred spots was defined. One F-D curve 
was recorded for every spot. In purple membrane the distance between 
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adjacent BR trimers corresponds to ≈6.2 nm. To ensure that single BR 
monomers were unfolded from intact BR trimers, the separation between 
adjacent spots was set ≈20 nm for purple membrane. To ensure that only 
one F-D curve per nanodisc was recorded, the distance between adjacent 
spots was set >50 nm for BRND. All SMFS experiments were performed 
using identical buffer solution (150 mM KCl, 20 mM Tris-HCl, pH 8.0) at 
room temperature. 
4.2.7 Selection and analysis of F-D curves  
First F-D curves were selected that exhibited an overall length 
between 60 nm and 70 nm, since they represented the complete unfolding 
of a BR into a fully stretched conformation (156). Then F-D curves were 
selected that corresponded to the C-terminal unfolding of BR (156, 296). 
All F-D curves were aligned using the characteristic force peak at a 
contour length of 88 amino acids as reference. Every force peak of a F-D 
curve was fitted using the worm-like chain (WLC) model (Section 2.8.2). 
Every force peak of every F-D curve was analyzed to quantify contour 
length and unfolding force (Figure 4.5). To determine the average force 
shown in histograms (Figure 4.5C,D) the average force of a particular 
force peak was calculated and multiplied by its probability of detection. 
This procedure gives the average force of an unfolding force peak from all 
unfolding F-D curves analyzed. 
4.2.8 Assignment of stable structural segments 
The contour length determined using the WLC model corresponds 
to the length of the unfolded and stretched BR polypeptide that tethers 
the AFM tip and a structural unfolding intermediate. Thus, each force 
peak was used to assign the end of the previous and the beginning of the 
following structural segment that stabilized BR against unfolding (125). 
Some stable structural segments had to be assumed to end or begin at the 
periplasmic BR surface at the opposite side of the pulling AFM tip. 
Therefore, the so-called ‘membrane compensation procedure’ was applied 
to correct the contour lengths (125, 159) (see section 3.2.5). 
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4.3 Results and discussion 
4.3.1 Mechanically unfolding single BR molecules from purple 
membrane and from nanodiscs 
After reconstituting BR into dimyristoylphosphatidylcholine 
(DMPC) lipid nanodiscs absorption spectra of native purple membrane 
(BRPM) and of BR in nanodiscs (BRND) were recorded (Figure 4.1A). 
BRPM and BRND showed similar absorption spectra between 450 and 650 
nm that are characteristic for the native light-driven proton pump BR 
(297). Thus, it can be concluded that reconstitution into lipid nanodiscs 
did not change the functional properties of BR significantly. To determine 
the assembly of BR in nanodiscs circular dichroism (CD) was used (294, 
295). The CD spectra of BRND showed peaks in the visible spectrum from 
400 to 700 nm (Figure 4.1B), which are typical for trimeric BR (298). The 
bilobed CD spectrum of BRND indicates that BR has been reconstituted 
into lipid nanodiscs as a trimer (298). In previous studies bilobed CD 
spectra indicating the BR trimerization could be only observed after 
heating the sample (298). However, a bilobed CD spectrum of BRND was 
observed without heating. This difference was attributed to the fact that 
a different detergent (β-OG compared to Triton-X used in (298)) to 
solubilize BR from purple membrane (see section 4.2). Consequently, BR 
trimers were reconstituted into lipid nanodiscs. 
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Figure 4.1: UV/vis and CD spectra. (A) UV/vis spectra of bacteriorhodopsin in purple 
membrane and of bacteriorhodopsin in nanodiscs. The co-factor specific absorption of 
BRPM and BRND at a wavelength of 560 nm is very similar. Differences were detected in 
the range between 250 and 440 nm. These changes might be caused by lower light 
scattering of the nanodiscs (272) compared to purple membrane. Spectra were recorded 
in buffer solution (100 mM NaCl, 40 mM Tris-HCl, pH 7.4) at room temperature. (B) 
Circular dichroism (CD) spectra of bacteriorhodopsin in nanodiscs. The presence of a 
positive (1) and a negative peak (2) in the visible CD spectrum indicates the existence of 
trimeric BR in BRND (298). The spectrum represents an average of 3 measurements. 
Spectra were recorded in buffer solution (100 mM NaCl, 40 mM Tris-HCl, pH 7.4) at 
20°C. 
For SMFS native purple membrane (BRPM) or BRND was adsorbed 
to mica and imaged by AFM in buffer solution (Figure 4.2) (143). 
Whereas purple membranes were heterogeneously distributed over the 
supporting mica, the BRND complexes were homogeneously distributed 
and densely packed. To attach a single BR via unspecific interactions to 
the AFM tip (156), the tip was brought into contact with the sample 
(BRPM or BRND) applying a force of ≈1 nN for 1 s. In ≈0.5% (BRPM, 
n≈20.000), or ≈0.05% (BRND, n≈250.000) of all cases a single BR molecule 
attached with its terminal end to the AFM tip (Figure 4.3). Withdrawal 
of the AFM tip stretched and stressed the terminal end and induced the 
unfolding of BR (156). The force-distance (F-D) curve recorded during 
withdrawal of the AFM tip showed a characteristic sawtooth-like pattern 
(Figure 4.4A,B) that has been assigned to the mechanical unfolding of 
BR from the C-terminal end (156, 159). 
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Figure 4.2: AFM topographs of purple membrane (A) and nanodiscs containing 
bacteriorhodopsin (BRND) (B). Purple membrane and BRND were adsorbed for 10 min 
onto freshly cleaved mica and imaged in buffer solution (300 mM KCl, 20 mM Tris-HCl, 
pH 8.0) at room temperature. Purple membranes have a diameter of 300-700 nm and 
BRND have a diameter of ≈10-20 nm. Both AFM topographs exhibit a full color scale 
corresponding to vertical scales of 15 nm. The AFM topograph in (A) was recorded using 
contact mode AFM applying a contact force of ≈100 pN (93) and the topograph in (B) was 
recorded using force-volume AFM applying a maximal force of ≈50 pN (299).  
 
 
Figure 4.3: Schematic representation of SMFS of bacteriorhodopsin (BR) 
embedded in native purple membrane (BRPM) and lipid nanodiscs (BRND). (A) 
and (B) are cartoons of BR trimers embedded in purple membrane (BRPM) and in a lipid 
nanodisc (BRND), respectively. After attachment of the AFM tip to the C-terminal end of 
a single BR molecule, the AFM tip is withdrawn to apply mechanical stress to the 
membrane protein. A force-distance (F-D) curve records the deflection of the AFM 
cantilever as a function of the distance (d) between AFM tip and membrane (Figure 
4.4A,B). F-D curves recorded of BRPM and BRND show that sufficiently high mechanical 
stress induces stepwise unfolding of the membrane protein. 
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Figure 4.4: Mechanical unfolding of bacteriorhodopsin in native purple 
membrane and in lipid nanodiscs. (A,B) Selection of F-D curves that record the 
unfolding of single BRPM (A) and BRND (B) molecules. Every force peak of every F-D 
curve detects an unfolding intermediate of BR with all force peaks (unfolding 
intermediates) describing the unfolding pathway taken by an individual BR molecule. 
(C,D) Superimpositions of 100 F-D curves recorded for BRPM (C) and for BRND (D). Red 
lines are WLC curves fitting the main force peaks that occur at a probability of 100%, 
whereas black dashed lines are WLC fits of minor force peaks that occur at probability 
<80%. The numbers next to each WLC curve assign the contour length (given in amino 
acids (aa) for every fit) of a force peak. This contour length approximates the length of 
the unfolded and stretched polypeptide. Gray scale bars allow evaluating how frequently 
individual force peaks were populated. 
In the experiments shown here, BR molecules could either attach 
unspecifically via the N-terminal or the C-terminal end to the AFM tip 
(Methods). As reported earlier the F-D curves showed a specific pattern 
depending from which terminal end BR was unfolded (296). However, the 
probability of the N-terminal end to attach to the AFM-tip was much 
lower than that of the C-terminal end (156, 296). Thus, for statistical 
reasons only F-D curves that reflected the unfolding of BR from the C-
terminal end were analyzed. The mechanical unfolding of BR from the C-
terminal end can be described as follows (156, 159). Upon separating the 
AFM tip from the support, the C-terminal end of the BR molecule is 
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stretched and a force builds up. As soon as the stretching force overcomes 
the stability of BR a structural segment directly connected to the C-
terminal end unfolds. This unfolding step extends the polypeptide linking 
the pulling AFM tip and the portion of the BR molecule that remains 
folded and anchored in the membrane. Continuously withdrawing the 
AFM tip stretches the previously unfolded polypeptide until the 
forthcoming structural segment is loaded, mechanically stressed and 
unfolded. The unfolding of structural segments forming stably folded 
entities continues until the entire BR molecule has been unfolded. This 
scenario explains that every single force peak of a F-D curve detects an 
unfolding intermediate of BR. The combination of all unfolding 
intermediates describes the unfolding pathway taken by the BR molecule. 
4.3.2 BR in purple membrane and in nanodiscs choose identical 
unfolding intermediates 
Using SMFS single BR molecules that were embedded either in 
native purple membrane or in lipid nanodiscs were repeatedly unfolded 
under identical experimental conditions (Figure 4.4A,B; Methods). 
Every force peak of every F-D curve records an unfolding intermediate of 
BR that had certain probabilities to be detected (136, 159, 232). An 
unfolding step describes the transition of one unfolding intermediate into 
the forthcoming one. Within such an unfolding step a structural segment 
of the BR molecule unfolds. The amplitude of a force peak quantifies the 
strength of the interaction that stabilizes a structural segment against 
unfolding. To visualize the common unfolding intermediates and steps of 
BR 100 F-D curves recorded of BRPM (Figure 4.4C) and 100 F-D curves 
recorded of BRND were superimposed (Figure 4.4D). Both 
superimpositions enhanced the force peaks that were common among all 
F-D curves (159). The superimpositions of F-D curves recorded of BRPM 
and of BRND did not show any considerable differences. 
To fit every force peak and to approximate the contour length of 
the stretched and unfolded BR polypeptide, the WLC model was used 
(Figure 4.4C,D). After having repeated this procedure for every force 
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peak of every F-D curve the positions of all force peaks detected were 
statistically analyzed (Figure 4.5A,B). Histograms of the force peak 
positions detected for the unfolding of BRPM and BRND showed minor 
differences. Student’s t-tests revealed that none of these differences was 
statistically significant (Table 4.1). This suggests that the unfolding 
intermediates that were assigned by the force peaks did not differ from 
both preparations. Thus, it can be concluded that the stable structural 
segments forming the unfolding intermediates of BR did not depend on 
whether the membrane protein was embedded in the native purple 
membrane or in lipid nanodiscs. 
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Figure 4.5: Probability and average force of unfolding intermediates of 
bacteriorhodopsin in native purple membrane (BRPM) and of 
bacteriorhodopsin reconstituted in lipid nanodiscs (BRND). (A,B) Probability of 
force peaks detected at certain contour lengths of BRPM (A) and BRND (B). (C,D) Average 
force of force peaks detected at certain contour lengths of BRPM (A) and BRND (B). The 
contour length of every force peak of every F-D curve (n=100 for each BRPM and BRND) 
was determined by WLC fits (Figure 4.4). Gaussian functions (red lines) were fitted to 
histograms to determine the average contour length of every peak including the 
standard deviation (fitted contour lengths in aa are given for every peak). Gray lines in 
(B) and (D) are Gaussian fits of the BRPM reference data (A) and (C), respectively. Bin 
sizes of histograms were 3 aa. Student’s t-tests did not reveal significant changes 
between BRPM and BRND (Table 4.1). 
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To assign the stable structural segments that established unfolding 
intermediates of the BR structure (Figure 4.6, Figure 4.7) the average 
contour lengths were used. The contour length of every unfolding force 
peak (Figure 4.5) was used to assign the beginning of a stable structural 
segment and the end of the previously unfolded structural segment (159). 
The stable structural segments detected for both BRPM and BRND were 
similar to the segments repeatedly detected before, using native purple 
membrane (126, 136, 253). This demonstrates that the unfolding 
intermediates shaping the unfolding pathway of BR in native purple 
membrane did not change upon reconstitution of BR into nanodiscs 
(Figure 4.7). 
 
Figure 4.6: Stable structural segments that establish unfolding intermediates 
of bacteriorhodopsin. (A) Top view of the BR trimer from the cytoplasmic surface. (B) 
Side view of the BR monomer. Numbers without brackets indicate the structural 
position (in aa) at which a force peak assigned the end of one stable structural stable 
segment and the beginning of the forthcoming structural segment. Numbers in brackets 
denote the corresponding residue (in aa) in the BR sequence (PDB ID 1FFB). Individual 
structural segments are equally colored. 
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Figure 4.7: Unfolding intermediates of BR. After attaching the AFM tip to the C-
terminal end the retracting AFM cantilever induces the mechanical unfolding of the BR 
molecule. In a first step the C-terminal end is stretched (unfolding intermediate 1). At 
sufficiently high force the first unfolding step occurs and transfers unfolding 
intermediate 1 into the unfolding intermediate 2. Within this unfolding step the 
structural segment highlighted in red unfolds. Subsequent retraction of the cantilever 
stepwise unfolds the BR molecule and stretches the unfolded polypeptide (unfolding 
intermediates 2-10). In the last unfolding step the remainder of the BR molecule is 
extracted from the membrane. The sequence of unfolding steps describes transition of 
one unfolding intermediate into the next one. The sequence of all unfolding 
intermediates describes the unfolding pathway taken by the BR molecule. As shown in 
Table 4.1 every unfolding intermediate of BR had a certain probability to occur. In some 
cases, one or more unfolding intermediates unfolded collectively in one unfolding step. 
Next the average force of every unfolding force peak detected was 
determined (Figure 4.5C,D). Histograms of the average unfolding forces 
showed minor differences between BRPM and BRND, which were 
statistically not significant (Table 4.1). Because the average unfolding 
forces quantify the strength of interactions stabilizing the unfolding 
intermediates of BR, this comparison shows that the interactions 
established in BR did not depend on whether BR was embedded in the 
native purple membrane or in lipid nanodiscs. However, it cannot be 
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excluded that more sensitive SMFS measurements in the future may 
allow detecting subtle differences. 
4.3.3 BRPM and BRND populate unfolding intermediates similarly 
In the previous chapter it was analyzed whether BR in native 
purple membrane and BR reconstituted in lipid nanodiscs show different 
unfolding intermediates and whether there is a difference in the 
interaction strengths stabilizing the individual unfolding intermediates. 
None of these analyses revealed significant differences. However, every 
unfolding intermediate occurred at a certain probability and the sequence 
of unfolding intermediates describes a particular unfolding pathway 
taken by the BR molecule. To characterize whether BR in purple 
membrane and BR in lipid nanodiscs populate unfolding intermediates 
and pathways differently, the probability for every unfolding 
intermediate that has been reproducibly taken by BR was analyzed 
(Figure 4.7, Table 4.1). The probability of every unfolding intermediate 
was obtained from the histogram providing the probability of single 
unfolding force peaks to be detected (Figure 4.4A,B). To determine the 
probability of a force peak described by a Gaussian distribution the 
number of F-D curves contributing a force peak to this distribution was 
counted and divided through the total number of F-D curves (Table 4.1). 
The unfolding intermediates described by the unfolding force peaks 
at contour lengths of 23, 88, 148 and 219 aa were detected at a probability 
of 100%. Therefore, they were named main unfolding intermediates. 
Other unfolding intermediates of BR were detected at lower probability, 
and were named minor unfolding intermediates. Thus, stressed at 
sufficiently high mechanical force the BR molecule always took the same 
main unfolding intermediates, whereas the minor unfolding 
intermediates were taken less frequently along the unfolding pathway. 
The probability of the less frequently occurring unfolding intermediates 
of BRND showed differences compared to those of BRPM (Table 4.1). 
However, these differences and the number of F-D curves analyzed were 
too small to verify significance (300). 
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From these results, it can be concluded that, compared to BR of 
native purple membrane, the reconstitution into lipid nanodiscs did not 
cause BR to populate unfolding intermediates differently. To further 
investigate whether there is a difference in the minor unfolding 
intermediates of BR more sensitive SMFS methods need to be 
established. 
4.3.4 Limited binding probability of the C-terminal end 
The probability to attach the C-terminal end of a BR molecule from 
purple membrane to the AFM tip was about 10 times higher (0.5%) 
compared to the probability of attaching the C-terminal end of a BR 
molecule in lipid nanodiscs (0.05%). Therefore, 10 times more 
experiments had to be conducted to obtain the 100 F-D curves from BRND 
in order to superimpose and analyze them in this work (Figure 4.4, 
Figure 4.5). Revealing statistical relevant number of F-D curves is 
mandatory to establish SMFS and dynamic force spectroscopy (DFS) 
assays to characterize membrane proteins (126, 135, 136, 229, 231, 253). 
Thus, the low attachment rate of BR from nanodiscs to the AFM tip 
makes it challenging to obtain sufficient amounts of F-D curves. Several 
scenarios appear feasible to increase the number of F-D curves recorded 
from nanodiscs. Most probably the nanodisc preparation characterized for 
the measurements also contained empty lipid nanodiscs without inserted 
BR. To overcome this problem, recombinant BR with an affinity tag could 
be used to separate in a further purification step empty nanodiscs from 
BRND. Furthermore, it is conceivable that in the preparation used in this 
work the nanodiscs adsorb onto the support with random orientation 
(Figure 4.2). Therefore, the functionalization of the support to favor a 
certain orientation of nanodiscs may increase the probability of the AFM 
tip to attach the terminal end of the membrane protein. Preferentially 
orienting nanodiscs may also help to reveal AFM topographs that show a 
sufficient high resolution to identify single BR molecules in the nanodisc. 
In addition, elongating one of the terminal ends of the membrane protein 
may be helpful to improve the attachment rate to the AFM tip. 
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4.4 Summary 
In previous SMFS experiments it was investigated whether 
temperature, mutations, ions, oligomeric assembly, activation, or 
molecular compounds modify or establish interactions that initiate the 
formation of new (un-)folding intermediates of membrane proteins 
embedded in their native lipid membrane (126, 129-133, 136). So far none 
of these experiments detected that a membrane protein establishes a new 
unfolding intermediate or stable structural segment. These results 
suggest that the unfolding intermediates and thus the stable structural 
segments established within functional membrane proteins are conserved 
(135, 233). However, when changing external and internal factors 
modulating the functional state and stability of a membrane protein it 
was observed that they could significantly change the probability of 
detecting certain unfolding intermediates by SMFS (127, 130-133). In 
most of these examples the probability to detect an unfolding 
intermediate increased with the strength of the interaction stabilizing a 
particular structural segment. Thus, the interactions stabilizing 
structural segments within membrane proteins depend sensitively on the 
environment. 
In the SMFS experiments presented here no significant changes of 
the interaction strengths stabilizing structural segments (unfolding 
intermediates) of BR embedded in purple membrane and of BR embedded 
in lipid nanodiscs (Figure 4.5, Table 4.1) were detected. To some extent 
this finding may be considered surprising because the assembly of BR in 
purple membrane is quite different from BR in lipid nanodiscs (Figure 
4.3). Additionally, although the phospholipid nanodiscs may contain 
residual lipids that have been co-extracted with BR from purple 
membrane, the overall lipid composition of nanodiscs certainly differs 
from the lipid composition surrounding BR in the native purple 
membrane. However, as the UV/vis absorption spectra of BR is sensitive 
to functional alterations (297) the largely unchanged absorption spectra 
suggests that the native structure and function relationship of BR was 
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maintained upon reconstitution into phospholipid nanodiscs (Figure 
4.1A). Because the functional characterization of BRPM and BRND reveals 
no significant differences one may infer that the inter- and 
intramolecular interactions within BR change very little. From this 
perspective it is not surprising that the SMFS experiments did not detect 
significant changes of interactions established of BRPM and BRND. 
Biochemical and biophysical studies showed that BR molecules natively 
assembled into the BR trimer are structurally and thermally more stable 
compared to monomeric BR molecules (136, 301, 302). Thus it can be 
assumed, that the individual BR molecule is significantly stabilized by 
intermolecular interactions formed within the native BR trimer. In the 
experiments the BR trimer was reconstituted into lipid nanodiscs 
(Figure 4.1B) without observing significant changes of the folding, 
stability and the interactions established in BR molecules. To which 
extend this effect may be attributed to the interactions stabilizing BR 
molecules within the BR trimer has to be shown. Although in the 
experiments the modified lipid environment of the nanodisc showed 
negligible influence on the function and stability of BR this may not be 
generalized for other membrane proteins. Particularly it has been shown 
that the lipid composition of membranes can functionally modulate 
membrane proteins (13, 14, 62, 303). Therefore, it may be too farfetched 
to conclude from the results that lipid nanodiscs do not change 
interactions of membrane proteins in general. It may be more realistic to 
conclude that SMFS of native membrane proteins can be conducted from 
lipid membranes and from lipid nanodiscs, and that the composition of 
lipid nanodiscs must be chosen carefully to maintain the native stability, 
structure and function of a particular membrane protein. 
In the experiments presented here no significant changes of the 
interactions determining the BR stability, unfolding intermediates, and 
unfolding pathways could be detected. Therefore it can be concluded that 
membrane proteins can be reconstituted into lipid nanodiscs to study 
their stability and folding using single molecule techniques such as 
SMFS. One advantage of using nanodiscs to study membrane proteins by 
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SMFS is that the reconstitution can be adjusted to the specific conditions 
required to maintain the native structure and function relationship of the 
membrane protein. The main advantage of this approach is that 
membrane proteins reconstituted into nanodiscs can be handled at 
similar ease as water-soluble proteins. Most importantly, membrane 
proteins in nanodiscs can be prepared for SMFS and investigated by 
SMFS similar to water-soluble proteins. Consequently, high-resolution 
AFM imaging to localize protein membranes is not required anymore for 
SMFS. This will enable performing high-throughput SMFS of membrane 
proteins in nanodiscs that homogeneously cover the SMFS support. Such 
high-throughput SMFS may allow screening for ligands or drugs that 
bind to the membrane protein of interest, for example to molecular 
transporters or G protein-coupled receptors (see section 3.1.1) (127, 130, 
132, 133). Furthermore, membrane proteins might be sandwiched into 
polyprotein constructs (304) and characterized with advanced SMFS 
approaches that have been developed and established using water-soluble 
proteins. Such approaches include using instrumentations that have been 
developed to significantly improve force sensitivity (305, 306), time 
resolution (307), throughput (285, 308, 309) and thermal stability (drift) 
(310) of the SMFS experiment and that are less well suitable for high-
resolution AFM imaging of biological samples. Taken together lipid 
nanodiscs will open new doors for the characterization of membrane 
proteins by SMFS. 
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5 Outlook 
After its invention in 1986 (90), AFM has emerged into an 
important tool for the investigation of both biological and non-biological 
specimen. AFM is constantly improved in terms of instrumentation, but 
also as a result of novel assays developed to address scientific questions. 
Although it has been invented to image surfaces, during the last 20 
years the AFM has been increasingly used to measure forces, for instance 
adhesion forces between individual ligand-receptor pairs (151, 311), cell 
adhesion (312), stretching of DNA (313) and polymers (314) and of course 
unfolding of (membrane) proteins (152, 156). All of these experiments had 
in common that they measured interactions in relation to the function of 
the investigated sample. Furthermore, these SMFS experiments 
measured the unfolding behavior of single molecules, in contrast to 
conventional chemical or biophysical denaturation and unfolding studies, 
which mainly address bulk properties of a large ensemble of molecules. 
It has been shown that SMFS is a valuable tool for investigating 
unfolding behavior and interactions stabilizing membrane proteins. 
Furthermore, SMFS-based DFS facilitates the characterization of the 
underlying energy landscape of the membrane protein. The application of 
SMFS and DFS made it possible to reveal functionally related changes 
within membrane proteins (125). 
Recently, attempts have been made to study the refolding of 
membrane proteins into lipid bilayers (138, 139, 315). However, these 
refolding experiments were based on unfolding experiments where at 
least one structural element remained anchored in the membrane. Thus, 
the mechanical refolding of the membrane protein did not reflect a native 
scenario. Covalently linking the membrane protein of interest to the AFM 
tip and studying its refolding into an unsupported lipid bilayer might 
open a new door for the investigation of membrane protein folding on a 
single-molecule level (92). The target membrane could be supplemented 
with protein refolding machineries that are known to assist proper 
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membrane protein folding in vivo, like the Sec- (316) or the BAM-complex 
(317). Additionally, the influence of chaperones on the refolding of 
membrane proteins could be investigated. 
In contrast to soluble proteins, which mainly unfold in a single 
step, membrane proteins are stabilized by a multitude of molecular 
interactions. However, unfolding spectra detect only a small subset of 
these interactions, which can be considered to be the prominent ones. In 
the future, high-resolution SFMS using ultrastable AFM setups will 
enable measurements that are sensitive enough to detect even minor 
interactions of membrane proteins (305, 306, 310). Combined with other 
techniques, as for example nanodiscs (318) (see chapter 4), SMFS might 
become an even more powerful tool to investigate the unfolding of 
membrane proteins in vitro. 
In order to understand how membrane proteins are controlled in 
vivo and to gain insight into cellular processes, SMFS needs to be 
transferred into living cells. This paradigm change of combining in vitro 
and in vivo SMFS is challenging (300). Nevertheless, such in vivo SMFS 
measurements will provide key insight into biomolecular interactions 
that drive the machinery in the highly complex and dynamic environment 
of the cell interior. 
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6 Appendix 
6.1 Abbreviations 
°C Degree Celsius 
2D Two-dimensional 
3D Three-dimensional 
Å Ångström (10-10 m) 
aa Amino acids 
AFM Atomic force microscope/microscopy 
BR Bacteriorhodopsin 
BRND Bacteriorhodopsin in nanodiscs 
BRPM Bacteriorhodopsin in purple membrane 
CD Circular dichroism 
CHS Cholesteryl hemisuccinate 
DFS Dynamic force spectroscopy 
DMPC Dimyristoylphosphatidylcholine 
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine 
EM Electron microscopy 
F-D curve Force-distance curve 
G protein Guanine nucleotide binding protein 
Gi Inhibiting G protein 
GPCR G protein-coupled receptor 
Gs Stimulating G protein 
h Hour 
HOPG Highly ordered pyrolytic graphite 
IG Immunoglobulin 
IMAC Immobilized metal ion affinity chromatography 
IPTG Isopropyl-β-D-thiogalactopyranosid 
J Joule 
min Minute 
mM Millimolar (10-3 mol/l) 
MSP Membrane scaffold protein 
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nm Nanometer (10-6 m) 
NMR Nuclear magnetic resonance 
nN Nanonewton (10-9 N) 
OD Optical density 
PC Phosphatidylcholine 
PDB Protein Data Bank 
PE Phosphatidylethanolamine 
PMSF Phenylmethanesulfonylfuoride 
pN Piconewton (10-12 N) 
PS Phosphatidylserine 
PSPD Position sensitive photodiode 
rHDL Reconstituted high density lipoprotein 
s Second 
SD Standard deviation 
Sf9 Spodoptera frugiperda 
SM Sphingomyelin 
SMFS Single-molecule force spectroscopy 
SPM Scanning probe microscope/microscopy 
STM Scanning tunneling microscope 
TEV Tobacco etch virus 
TRIS 2-Amino-2-(hydroxymethyl)-1,3-propanediol 
WLC Worm-like chain 
β-OG n-octyl-β-D-glucopyranoside 
β2AR Human β2 adrenergic receptor 
µm Micrometer (10-6 m) 
6.2 Symbols !∗ Most probable rupture/unfolding force [N] !! Unfolding rate in absence of force [s-1] !! Boltzmann constant (1.3810-23 J/K) 
Kd Dissociation constant !! Contour length [m] !! Persistence length [m] 
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!!∗ Most probable loading rage [N/s] !! Loading rate [N/s] !! Distance between native and transition state [m] !!"#$%& Spring constant of the polymeric handle connecting 
cantilever tip and molecule (e.g. already unfolded 
polypeptide chain) [N/m] !! Diffuse relaxation time [s] ∆!!‡ Free energy of activation [J] ! Young’s modulus [N/m2] ! Force [N] ! Spring constant [N/m] 
Q Quality factor ! Temperature [K] ! Mechanical rigidity of a structural segment [N/m] 
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